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Abstract 
The kiss system is a well-known regulator of the brain-pituitary-gonadal (BPG) axis in 
vertebrate reproductive physiology, and is expressed in the brain throughout the vertebrate 
subphylum (except in birds). This system consists of kiss neurons excreting kiss ligands that 
bind the receptor GPR54. Apart from its role in control of reproduction, kiss has been found 
to inhibit cell migration in cancer cells. However, less is known about its other physiological 
functions, especially in non-mammalian species like teleosts. Teleosts make up the largest 
group of the extant vertebrate species, making their genome evolution and diversification 
important subjects for investigation of vertebrate vide physiological functions. In this study 
the expression pattern of one of the kiss receptor paralogs is investigated in the brain of adult 
medaka (Oryzias latipes) by a fluorescent in situ hybridization (FISH) assay. The work 
included the development of a FISH assay adapted to medaka, and generation and validation 
of a probe specific for the medaka kiss receptor gpr54-chr9. The results show expression in 
areas proven to be important in regulating reproduction, like in the ventral telencephalon and 
in the preoptic areas of the hypothalamus. Further, the FISH method was adapted to suit an 
embryonic model of medaka. Knockdown of the kiss system is recently found to cause 
abnormal embryonic development in medaka, possibly by acting on neural migration and 
brain formation. I established both a single – and double FISH method for use in embryos, 
which can potentially be used to map the expression of kiss and kiss receptors through 
embryogenesis in medaka.  
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List of abbreviations: 
  
Ab  Antibody 
ARC  Arcuate nucleus 
BPG  Brain-pituitary-gonadal 
cDNA  Complementary DNA 
CDS  Coding DNA sequence 
Chr   Chromosome  
DAPI 4’,6-diamidino-2-
phenylindole 
DIG   Digoxigenin 
Dnp  Dinitrophenol  
dNTP  deoxynucleotide 
triphosphate 
dpf  Days post fertilization 
DTT  Dithiothreitol 
FISH  Fluorescent in situ 
hybridization  
FITC  Fluorescein 
FSH  Follicle-stimulating hormone 
GnRH  Gonadotropin-releasing 
hormone 
HB  Habenula 
Hpf  Hours post fertilization  
HybMix Hybridization mix solution 
HybWash Hybridization wash solution 
ISH   in situ hybridization 
KO  Knock out 
LH  Luteinizing hormone 
LI  Lobus inferior 
M13F  M13 forward primer 
M13R   M13 reverse primer 
MAB   Maleic acid buffer  
MCS  Multiple cloning site 
mRNA Messenger RNA 
MS-222 Tricaine methanesulfonate 
NAT  Nucleus anterior tuberis 
NFLM  Nucleus fasciculus 
longitudinalis medialis 
NPPv  Nucleus posterioris 
periventricularis 
 
NRL  Nucleus recessus lateralis 
NVT  Nucleus ventralis tuberis 
OT  Optic tectum 
PBS  Phosphate buffered saline 
PBST  Phosphate buffered saline 
tween-20 
PCR  Polymerase chain reaction 
PFA  Paraformaldehyde 
PK  Proteinase K 
POA  Preoptic area 
POD  Peroxidase  
POm  Nucleus preopticus pars 
medialis 
Pop  Nucleus preopticus pars 
parvocellularis 
RT  Room temperature 
SSC  Saline-sodium citrate 
buffer 
TAMRA 5-carboxytetramethyl-
rhodamine 
TE  Telencephalon 
TSA  Tyramide signal 
amplification 
UTP  Uridine triphosphate 
V  Area ventralis telencephali 
Vd  Area ventralis telencephali 
pars dorsalis 
Vi  Area ventralis telencephali 
pars intermedia 
Vl  Area ventralis telencephali 
pars lateralis 
Vp  Area ventralis telencephali 
pars posterior 
Vs  Area ventralis telencephali 
pars supracommissuralis 
Vv  Area ventralis telencephali 
pars ventralis 
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1 Introduction  
In this thesis the gene expression pattern of the kiss receptor, gpr54, was investigated in 
medaka (Oryzias latipes, the receptor paralog gpr54-chr9 in this species). The experiments 
were performed both on brains from adult medaka and on embryos, using fluorescent in situ 
hybridization as the main method. The information available concerning the kiss system is 
mostly restricted to regulation of reproductive function in the mammalian brain. I have 
focused my experiments mainly on the teleost brain, but also on the embryonic expression 
pattern – a life stage during which very little is known about the function of the kiss system.  
1.1 Medaka as a model organism 
Using teleosts as models instead of mammals can have several advantages (Powers, 1989). 
Most teleosts are oviparous, and embryonic development therefore occurs externally. The 
embryos are often transparent throughout most of the developmental stages, which is a huge 
advantage when observing the development of the brain, enabling in vivo studies. In addition, 
teleosts make up the largest group of vertebrates, and comprise more than half of all extant 
vertebrate species. They have throughout evolution adapted to a variety of marine and 
freshwater habitats. Their genome evolution and diversification are important subjects for the 
understanding of vertebrate evolution, and gives many opportunities in the study of different 
physiological phenomena or specific adaptations. Finally, comparative investigations between 
different species can reveal novel information about specific mechanisms. 
Medaka (Oryzias latipes), is a small freshwater teleost fish native to Japan, Korea and China 
that is widely used as a model organism because of its many advantages (Kasahara et al., 
2007; Kirchmaier et al., 2015). It has a short generation time, it is a diurnal species that 
spawns every morning provided proper environmental and social breeding conditions, and has 
low husbandry costs. Further, it is highly thermotolerant, as it naturally tolerates temperatures 
as high as 40 °C in the summer and temperatures down to 4 °C in the winter. Being a 
poikilothermic animal, the rate of embryonic development is highly dependent on 
temperature, with reduced temperatures decreasing the speed of development. The genome 
size of the medaka is relatively small compared to other small model fish, with a genome size 
estimated to be around 800 megabase pairs, this is less than half of the zebrafish (Danio rerio) 
genome size of approximately 1700 megabase pairs, and about one-third that of the human 
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genome (Naruse et al., 2004). The medaka genome is sequenced and easily accessible in the 
genomic database of medaka (http://utgenome.org/medaka/) and in NCBI and Ensembl. In 
addition, several inbred strains are established, as medaka seems remarkably tolerant to 
inbreeding. This is highly useful for both mutagenesis screening and genetic mapping. Among 
the several available inbred strains are the Hd-rR, all derived from offspring of a single stock 
of d-rR strain at Nagoya University, Japan in 1980 (Kinoshita et al., 2009). This inbred Hd-rR 
strain was utilized for the medaka genome sequencing project. The d-rR strain is 
characteristic by its body-color sexual dimorphism, which makes it especially suitable for 
experiments related to sex determination and differentiation. For the experiments performed 
in this thesis, fish of the d-rR strain was used.  
In the following chapters, a short introduction to the anatomy of medaka embryonic 
development and the medaka brain is given.  
1.2 Medaka embryonic development 
The developmental pathway of different tissues and organs through the embryonic stages is 
described by Iwamatsu (2004), and consists of 39 stages, from fertilization until hatching. The 
time of fertilization is set to stage 1, followed by rapid synchronized cell division occurring 
through the following stages. The stages 10-11 of development are considered the blastula 
stages, where the cells begin to divide asynchronously relative to their neighboring cells. At 
this time the cells start to migrate, and a blastoderm is formed. Further, at the gastrula stages, 
stage 12-16, an involution of the blastoderm gives rise to the developing epiblast and 
hypoblast that will form the ectoderm and the endoderm/mesoderm respectively. A local 
accumulation of cells gives rise to the dorsal lip, which will develop into the embryonic 
shield. At the end of gastrulation the embryonic shield is visible as a thin streak. The medaka 
brain development begins at late gastrulation (Kage et al., 2004). In late gastrulation at stage 
16 and the neurula steps at stage 17-18 the anterior part of the embryonic body thickens to 
generate the brain rudiment. By stage 19, the brain becomes divided into anterior-, 
intermediate-, and posterior brain vesicles in the early neural rod step. The anterior brain 
vesicle develops into the telencephalon and rostral diencephalon, including the hypothalamus. 
The intermediate brain vesicle develops into the caudal diencephalon, mesencephalon, and 
cerebellum, whereas the posterior brain vesicle develops into the medulla oblongata. See next 
section for description of the brain anatomy in adult medaka. At the late neural rod step, stage 
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22, formation of ventricles occurs, leading to the transformation of the neural rod into a neural 
tube. At the same time the heart rudiments develop in the embryo, and at stage 23 blood 
vessels appear in the yolk (Iwamatsu, 2004). At the next stages, 24-25, the first heartbeats 
appear, and the blood starts circulating in the embryonic body. During the neural tube steps, 
stage 23-27, the developing brain goes through a series of changes specific for teleost species 
(Kage et al., 2004). During brain development in teleosts, an outward bending (an eversion) 
of the dorsal portion of the lateral walls in the neural tube is seen, instead of an inward 
bending (an inversion) seen in most other vertebrates, mammals included (Nieuwenhuys, 
2011). This developmental pathway gives rise to a characteristic T-shaped ventricle in 
transverse sections of telencephalon in teleosts, compared to the two lateral paired ventricles 
found in other vertebrates (Yamamoto, 2009). Further, in the late embryonic steps of brain 
development, stages 28-34, the main nerve fiber systems arises (Ishikawa, 1997). Gray and 
white matter start filling up much of the ventricular spaces. Finally, during the fry brain step, 
stage 35 and until hatching, the brain matures. This maturation continues to the larvae stages, 
where the brain matures and becomes more similar to the adult medaka brain. At the later 
stages, different organs and systems develop and mature towards hatching, and the embryo 
gradually increases in size. The larvae hatches at stage 39, when the egg envelope rips open 
by a combined effect of hatching enzymes and rapid body movements.  
1.3 Anatomy of the medaka brain 
Medaka brain atlas from Ishikawa et al. (1999) shows the anatomical features of the adult 
medaka brain. The brain of the medaka share the basic architecture with other vertebrate 
species in that it can be divided into the main parts prosencephalon (forebrain), 
mesencephalon (midbrain) and rhombencephalon (hindbrain). The prosencephalon consists of 
the telencephalon and diencephalon, the mesencephalon consists of the optic tectum and 
tegmentum, and the rhombencephalon consists of the cerebellum and medulla oblongata 
(Ishikawa et al., 1999; Yamamoto, 2009). But, despite this similar division of the main parts 
of the brain, the location of the different homologous brain areas are quite different between 
the teleosts and other vertebrate species (Nieuwenhuys, 2011) because of the teleost specific 
brain eversion during development described in the previous section.  
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Figure 1. Anatomy of the medaka brain. TE, telencephalon; DI, diencephalon; OT, optic tectum; T, 
tegmentum; CE, cerebellum; MED, medulla oblongata. Figure modified from Ishikawa et al. (1999). 
 
When the brain is sectioned from the anterior to posterior end, the resulting transverse 
sections reveal many interior brain areas (Ishikawa et al., 1999; Kanda et al., 2013; 
Yamamoto, 2009), illustrated in Figure 2. In the most anterior sections the different areas of 
the telencephalon (TE) can be seen (Figure 2 A-D). In the central part, the ventral 
telencephalon (area ventralis telencephali, V) is located; pars dorsalis (Vd), pars ventralis 
(Vv), pars posterior (Vp), pars supracommissuralis (Vs), pars intermedia (Vi) and pars 
lateralis (Vl) respectively. More posterior, the preoptic areas of the hypothalamus emerges 
ventrally, including the preoptic area (POA), the nucleus preopticus pars medialis (POm) and 
nucleus preopticus pars parvocellularis (POp) (Figure 2 C-D). Notice that the preoptic areas is 
a collective term of all the three respective areas, and is not to be mistaken with the exact 
brain location of the POA. As the telencephalon reaches its posterior end, habenula (HB) is 
seen dorsally in the section (Figure 2E). In the next sections we find the optic tectum (OT) at 
the dorsal side, and hypothalamus at the ventral side, with the nucleus ventralis tuberis (NVT) 
emerging most dorsally (Figure 2 F-H). In the central regions of these sections, and dorsally 
in the hypothalamus, the nucleus posterioris periventricularis (NPPv) and nucleus anterior 
tuberis (NAT) can be found. In the last sections (Figure 2 I-J) the cerebellum is seen in the 
dorsal part, and lobus inferior (LI) of the hypothalamus at the ventral part. Even further back 
the medulla oblongata is found before we reach the spinal cord (not shown).  
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Figure 2. The medaka brain (transverse sections). Transverse brain sections, anterior to posterior. Dorsal side 
of the brain points upwards in each section on the figure, and ventral parts points downwards. A-D: the 
telencephalon (TE) makes up the dorsal part, while preoptic areas emerges ventrally (C and D), including 
preoptic area (POA), nucleus preopticus pars medialis (POm) and nucleus preopticus pars parvocellularis (POp). 
The area ventralis telencephali (V) is located in the central part; pars dorsalis (Vd), pars ventralis (Vv), pars 
posterior (Vp), pars supracommissuralis (Vs), pars intermedia (Vi) and pars lateralis (Vl) respectively. E: 
Telencephalon reaches its posterior end and habenula (HB) emerges dorsally. F-H: The optic tectum (OT) is seen 
at the dorsal side, and ventrally the nucleus ventralis tuberis (NVT) of the hypothalamus is found, while the 
nucleus posterioris periventricularis (NPPv) and nucleus anterior tuberis (NAT) of the hypothalamus is seen 
centrally. I-J: cerebellum (CE) is seen in the dorsal part, and lobus inferior (LI) of the hypothalamus at the 
ventral part. The hindbrain is not shown. ca, commissura anterior; ch, commissura horizontalis; CM, corpus 
mamillare; ct, commissura transversa; Dc, area dorsalis telencephali pars centralis; Dd, area dorsalis telencephali 
pars dorsalis; dDI, dorsal region DI; dDm, dorsal region Dm; DI, area dorsalis telencephali pars lateralis; DM, 
nucleus dorsomedialis thalami; Dm, area dorsalis telencephali pars medialis; Dp, area dorsalis telencephali pars 
posterior; flm, fasciculus longitudinalis medialis; fr, fasciculus retroflexus; GR, corpus glomerulosum pars 
rotunda; lfb, lateral forebrain bundle; mfb, medial forebrain bundle; nII, nervus opticus; NC, nucleus corticalis; 
NDLI, nucleus diffuses lobi inferioris; NDTL, nucleus diffuses tori lateralis; NE, nucleus entopeduncularis; 
NFLM, nucleus fasciculus longitudinalis medialis; NIP, nucleus interpeduncularis; NR, nucleus ruber; NRL, 
nucleus recessus lateralis; PGc, nucleus preglomerulosus pars medialis commissuralis; PGm, nucleus 
preglomerulosus pars medialis; pTGN, preglomerular tertiary gustatory nucleus; TL, torus longitudinalis; TS, 
torus semicircularis; VM, nucleus ventromedialis thalami. Figure modified from Kanda et al. (2013).  
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1.4 The kiss system 
The kiss system includes the kiss neurons secreting kisspeptins (ligands) and their putative 
kiss receptors on the innervated cells.  
 
Figure 3. Kiss neuron and kiss receptor. The Kiss neuron excretes ligands, called kisspeptins. Kisspeptins 
binds kiss receptors on innervated cells, thereby activating the receptor. 
  
The kisspeptins are proteins expressed by the kiss gene. The resulting polypeptide is 
processed into bioactive peptides of variable length, in mammals that is either a 54, 14, 13 or 
10 -amino acid peptide, all including a well conserved 10 amino acid sequence called 
kisspeptin-10 (Oakley et al., 2009; West et al., 1998). These kisspeptins are related to the RF-
amide superfamily of neuropeptides, which possess an Arginine (R) and a phenylalanine (F) 
motif at their C-terminus, -Arg-Phe-NH2. The kiss receptors, called GPR54, are of the G-
protein-coupled receptor superfamily and belong to the rhodopsin family, characterized by 
seven transmembrane domains (Oakley et al., 2009). Screens for additional ligands that bind 
the kiss receptor have revealed several candidates, but with varied binding abilities (Clements 
et al., 2001).  
1.4.1 Evolutional relationship of the kiss system genes 
Several different homologs of the kiss system genes are found throughout the vertebrate 
subphylum. Phylogenetic and synteny analyses made it possible to reveal kiss/kiss receptor 
classifications, and gave information about the evolution of these gene families. In 2012 a 
proposed overview of this relationship was published (Pasquier et al., 2012b), where the 
evolution of both gene families could be traced back to the early steps of vertebrate history. 
The different homologs of kiss system genes found among vertebrates are a result of gene 
duplication events. Gene duplications have had a major impact on genome evolution, shaping 
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the vertebrate genomes, with whole genome duplications working as a dominant force (Lu et 
al., 2012). When replicates of a gene emerge, it gives room for rapid evolution of one of the 
two forms, which may give rise to new gene function. Whole genome duplication could 
therefore increase the frequency of genome evolution drastically. The 2R hypothesis suggests 
that the relatively large and complex vertebrate genome seen today is a result of two ancient, 
whole genome duplication events arisen in the ancestral vertebrate (Dehal and Boore, 2005). 
These two events led to a fourfold replication of the total genome, which can still be detected 
in the structure of the genomes of today’s vertebrates, since several gene families still present 
up to four variants of each gene. In the teleost lineage, an additional third round of whole 
genome duplication (3R) has occurred. The teleost-specific genome duplication event resulted 
in up to eight paralogous gene variants of the genes (Meyer and Van de Peer, 2005). Based on 
synteny analysis, Pasquier et al. (2012b) found that four kiss paralogs and four kiss receptor 
paralogs were likely generated via these two rounds of genome duplication in the early 
vertebrates. This was followed by multiple independent gene loss events of both Kiss and 
Gpr54 through evolution, leading to a reduction of the kiss system gene homologs to the 
numbers found in living species today. However, it seems that all replicates for kiss and kiss 
receptor genes resulting from this teleost-specific genome duplication was lost, shown in 
genomic synteny maps for the areas around kiss genes, Kiss, and kiss receptor genes, Gpr54 
(Pasquier et al., 2012b).The massive gene loss events of the kiss genes have resulted in only 
two homologous forms of Kiss present throughout the vertebrate subphylum in the species 
today (Lee et al., 2009). In all the mammalian species investigated (except the mammalian 
platypus; Ornithorhynchus anatinus), only one paralogous version of the gene is found: Kiss1, 
while fish species have two paraloguos variants: kiss1 and kiss2. The non-mammalian kiss1 
gene was found to be the ortholog of the mammalian variant, whereas the kiss2 was found to 
be a novel form. Birds on the other hand, have lost all their kiss genes through evolution 
(Pasquier et al., 2014). Regarding the kiss receptor, all four homologous forms are still found 
in the vertebrate subphylum, but most species possess fewer (Pasquier et al., 2012a). These 
four homologs are sorted in separate clades; Kissr-1 clade, Kissr-2 clade, Kissr-3 clade and 
Kissr-4 clade. Only one paralogous variant of the kiss receptor gene is known in mammals 
(except the mammalian platypus (Ornithorhynchus anatinus)), Gpr54-1. The mammalian 
Gpr54-1 gene is found among the Kissr-1 clade. Fishes show great variation between species 
when it comes to the number of kiss receptor paralogs, with two species, the coelacanth 
(Latimeria chalumnae) and the spotted gar (Lepisosteus oculatus), having representatives in 
every clade. At least one of the four different fish receptor paralogs is found to be present in 
 18
 
all fish species investigated so far, and is found among the Kissr-2 clade. The medaka and 
zebrafish species both have two kiss receptor gene paralogs, found in the Kissr-2 and Kissr-3 
clades. Regarding these to teleost species, no mammalian ortholog (Kissr-1 clade) is found. 
As for the ligand, birds have lost all kiss receptor genes through evolution (Pasquier et al., 
2014). 
There are major disagreements concerning the kiss receptor nomenclature in the literature, 
especially in the medaka (see Table 1). Throughout this thesis the general receptor name in 
use will be GPR54, and in medaka the two kiss receptors will be named Gpr54-chr17 and 
Gpr54-chr9, belonging to the suggested Kissr-2 and Kissr-3 clade respectively, following the 
analyses of Pasquier et al. (2012a). This nomenclature is based on the gene location in the 
medaka, located on chromosome 17 (gpr54-chr17) and 9 (gpr54-chr9).  
Following is an overview of the different kiss receptor names in use.  
Table 1. Kiss receptor gene nomenclature.  
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The table gives an overview of the nomenclature regarding the two kiss receptor genes in medaka. Because there 
seems to be some confusion and disagreements about the nomenclature of these genes we include the 
chromosome location of the genes in the gene names; gpr54-chr9 and gpr54-chr17 (gene location on 
chromosome 9 and 17, respectively). 
 
During my thesis the receptor paralog in focus will be the gpr54-chr9. The decision to 
investigate this receptor, in contrast to gpr54-chr-17, was based on the temporal expression 
pattern found by Hodne et al. (2013), descried in detail later. In short this study reveals an 
exceptionally early expression of this gene, which occurs in parallel with kiss1 expression. In 
addition, knockdown of each of the two genes gives the same phenotypic effect in embryo, 
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which might suggest a coupling of gpr54-chr9 and kiss1 in early embryogenesis, which 
makes investigating this paralog particularly interesting.  
As explained above, several Kiss- and Gpr54 gene homologs are present throughout the 
vertebrate subphylum, but the genetic variability between them is sparse (Lee et al., 2009). An 
alignment of the kisspeptin amino acid sequences showed that the conserved core sequence of 
kisspeptin-10 is well preserved between species of vertebrates; just differed by a couple of 
amino acids. The similarity was confirmed by receptor treatment with synthetic kisspeptins 
resembling KISS1 and KISS2, which activated all types of GPR54, although with different 
affinity (Lee et al., 2009). This might reflect a high grade of conservation of the bioactive 
parts in the ligand/receptor coupling.  
1.4.2 The kiss system’s role in the vertebrate 
The kisspeptins were first discovered as metastasis suppressors, having anti-metastatic effects 
on human malignant melanoma cells (Lee et al., 1996), by inhibiting cell mobility and 
suppress cell proliferation (Hori et al., 2001). The kiss gene was originally termed metastin 
because of this effect. The kiss receptor, GPR54 was discovered a few years later, when 
cloned from rat brain (Lee et al., 1999).  
It was later known that the kiss system also has a central role as a major gatekeeper of 
reproduction in vertebrates, after studying kiss mutations leading to hypogonadotrophic 
hypogonadism in humans (de Roux et al., 2003; Seminara et al., 2003), and metastin was then 
co-named Kiss. Hypogonadotropic hypogonadism is defined as a deficiency of the pituitary 
secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which results 
in impaired pubertal maturation and reproductive function. Mouse knockout (KO) models for 
both the kiss ligand and the receptor have been established and phenocopy the human disease 
in that both models lead to infertility (Funes et al., 2003; Lapatto et al., 2007; Seminara et al., 
2003). These studies linking loss of function of kiss ligand/receptor to reproductive deficiency 
identified GPR54 and kisspeptins as major players in the brain-pituitary-gonadal (BPG) axis, 
where gonadotropin-releasing hormon GnRH neurons in the hypothalamus stimulates the 
gonadotrophes of the pituitary to release FSH and LH, which in turn will stimulate 
gametogenesis and the production of sex steroids (Clarke and Pompolo, 2005). The current 
model in mammals suggest that the kiss system act as regulators of the BPG-axis by kiss 
neurons working as primary transducers of major endogenous and environmental cues, which 
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then provide an integrated signal, directly or indirectly through interneurons, to the GPR54 
containing GnRH neurons (Oakley et al., 2009; Popa et al., 2008). Such endogenous cues 
could be gonadal steroids (e.g. estradiol, progesterone and testosterone) working by a 
feedback mechanism, or different metabolic factors (e.g. leptin). Environmental cues 
influencing the system could be information related to photoperiod and season, possibly 
mediated by melatonin.  
In the teleosts, the BPG-axis work by the same principals, with only minor differences from 
the mammalian BPG-axis (Weltzien et al., 2014). The influence of the kiss system in 
regulating the axis is less studied in teleosts than in mammals, but several studies indicate a 
regulatory role here as well. A study in European sea bass (Dicentrarchus labrax) show that 
stimulation by Kiss2 gave a clear positive effect on the gonadotropin synthesis and release, 
while Kiss1 stimulation had less effect (Felip et al., 2009). The same was found in zebrafish 
(Kitahashi et al., 2009), which might suggest that the Kiss2 ligand is the most potent activator 
for gonadotropin secretion in some fish species. However, in the medaka it is found that kiss1, 
but not kiss2 neurons are sensitive to steroids, and thus it is most likely Kiss1 that regulates 
the gonadotropin release in this species (Mitani et al., 2010). Also the location of kiss neurons 
in the brain suggest that Kiss1 is the variant controlling reproductive function in medaka, as it 
is found in the NVT area in hypothalamus, with projections to the pituitary (Hasebe et al., 
2014). In contrast, zebrafish has no kiss1 neurons in this area, but kiss2 can be found here 
(Kanda and Oka, 2012).  
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Figure 4. Direct kiss system regulation of BPG-axis. The kiss system is shown to regulate the BPG axis in 
vertebrates (here illustrated in mammals). Kiss neuron activity is regulated by different endogenous- and 
environmental cues. Activation releases kiss ligands, kisspeptins, which bind kiss receptors on the GnRH 
neurons. Stimulation of these neurons results in secretion of GnRH, which stimulates the release of FSH and LH 
from the gonadotrophes. FSH and LH will in turn stimulate gametogenesis and the production of sex steroids. 
Note that the different cells and organs in this figure are not in proportion to each other, and is just a simplified 
illustration of the regulatory pathway. FSH, follicle-stimulating hormone; GnRH, gonadotropin-releasing 
hormone; LH, luteinizing hormone.  
1.4.3 Kiss system gene expression in the brain 
Because of its important role in regulating the BPG axis, the kiss system’s expression patterns 
in the brain have been investigated in several vertebrate species. In the mammalian brain the 
kisspeptins are expressed by two main populations of neurons in the hypothalamus, one 
within the preoptic area (POA) and one within the arcuate nucleus (ARC; Franceschini and 
Desroziers, 2013). 
In the zebrafish and medaka kiss1 and kiss2 spatial expression patterns are mapped in the 
brain. These expression maps reveal a different pattern of expression between these two 
teleost species. In the zebrafish kiss1 is only found in the habenula (HB), while kiss2 is 
distributed in the nucleus ventralis tuberis (NVT), the nucleus posterioris periventricularis 
(NPPv) and the nucleus recessus lateralis (NRL; Kitahashi et al., 2009; Servili et al., 2011). In 
medaka kiss1 expression is found in the habenula (HB), as well as in the nucleus ventralis 
tuberis (NVT) and nucleus posterioris periventricularis (NPPv), while kiss2 is found only in 
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nucleus recessus lateralis (NRL; Kanda et al., 2008; Kitahashi et al., 2009; Mitani et al., 
2010). The medaka kiss1 neurons localized in NVT, are found to have neural projections to 
the pituitary (described above), but also to the preoptic areas in the hypothalamus and ventral 
telencephalon (Hasebe et al., 2014).  
A study carried out in medaka has revealed the spatial expression pattern of the kiss receptor 
genes gpr54-chr17 and gpr54-chr9 in the brain of this species, done by nonradioactive, 
classical in situ hybridization on brain slices (Kanda et al., 2013). The in situ hybridization 
study revealed that the gpr54-chr17 was widely distributed throughout the brain at many 
specific areas, while the expression of gpr54-chr9 was more restricted to a couple of areas. 
gpr54-chr9 was mainly expressed by neurons in the prosencephalon, where the expression is 
restricted to large cells in the preoptic area (POA), and both large and small cells in the 
dorsomedial areas; nucleus preopticus pars magnocellularis (POm) and nucleus preopticus 
pars parvocellularis (POp). Expression is also found in several ventral parts of the 
telencephalon, like the area ventralis telencephali pars dorsalis (Vd), area ventralis 
telencephali pars supracommissuralis (Vs), area ventralis telencephali pars posterior (Vp). 
There was also detection of mRNA in the most posterior part of the telencephalon the 
habenula (HB). 
1.4.4 Additional roles of the kiss system 
Kiss and Gpr54 expression are found not only in the brain, but also in other tissues. Kiss is 
reported in several human organs, like the testis, pancreas, liver and small intestine (Oakley et 
al., 2009), while Gpr54 is reported in the spinal cord and pancreas. In mice kiss receptor are 
found in additional tissues, like in the heart, the aorta and in the kidneys (Sawyer et al., 2011). 
Further, both genes are found to be expressed in the placenta (Mead et al., 2007) with a 
relatively stable high expression level of the receptor, and a changing Kiss level throughout 
the pregnancy. This widespread expression pattern might indicate additional roles of the kiss 
system other than tumor suppression and reproductive control.  
There are several studies today indicating additional roles of the kiss system, which might 
reflect a diversity of intracellular signaling pathways triggered by GPR54 receptor activation, 
with many mechanisms yet to be revealed (Castaño et al., 2009). Thus, in total the kiss system 
shows a diverse aspect of functions in the adult vertebrate, but less is known about its 
expression and function during postnatal and pubertal development, and in embryogenesis 
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and early development. Information regarding this is now beginning to be revealed (Sandvik 
et al., 2014).  
1.4.5 The kiss system during vertebrate development 
Kiss system during development in mammals  
Very little is known about the kiss system during mammalian embryogenesis. There might be 
several reasons for this. Mammals often have an extended time of gestation compared to other 
vertebrates, and are in addition viviparous vertebrates, which is a huge disadvantage when it 
comes to studying embryonic development in vivo. In addition it is known that Kiss and 
Gpr54 knockout (KO) mice are infertile (Lapatto et al., 2007). KO animals therefore have to 
be generated by crossing of heterozygous parents, thus enabling maternal mRNA to be 
transferred from the mother to the embryo in the early developmental stages. Despite this, a 
couple of studies of the developing kiss system have recently been performed in mammals, 
mainly on mice and rats.  
In the rodent species, there is a tendency of early onset of Kiss and Gpr54 expression in the 
brain. The early expression of Kiss1 is mainly restricted to the ARC area, and is detected 
already prenatally in both mice (Fiorini and Jasoni, 2010) and rats (Desroziers et al., 2012). At 
the same embryonic stage Gpr54-1 expression was detected in POA in mice (Fiorini and 
Jasoni, 2010). This offset corresponds to the time that the first GnRH neurons reach their 
target, and an effect of KISS1 from ARC acting on these early GnRH neurons through the 
kiss receptor is suggested. Kiss1 expression in the POA is not detectable until postnatal stages 
in both mice (Semaan et al., 2010), and rats (Navarro et al., 2004), and in both species the 
expression increases until puberty is reached (Franceschini and Desroziers, 2013; Navarro et 
al., 2004). It is clear that rodents show an early, prenatally expression of Kiss1 and Gpr54-1 in 
ARC, that might indicate a functional kiss system already at these current stages, but the 
function of this developmental kiss system gene expression is still unclear. To examine the 
early effect of the kiss ligand on GnRH neurons further, Fiorini and Jasoni (2010) performed 
a study on embryonic POA brain tissue from mice ex vivo, where KISS1 was shown to 
stimulate both the number and length of the GnRH neurons.  
Also during human development, kiss and kiss receptor has been reported (Guimiot et al., 
2012). Immunostaining of brain sections from human fetuses revealed presence of both 
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proteins, KISS1 and GPR54-1 in the hypothalamus at the second trimester of development 
(15th week of gestation), and the protein level increased until the third trimester 
measurements (30-31th week of gestation), before a decrease at the end of gestation. 
However, nothing is known about the function of the kiss system in these early human 
developmental stages. 
Kiss system during development in teleosts  
Only a few studies are performed that investigate the physiological regulation and function of 
the kiss system during early teleost development, and they are mainly performed by using 
zebrafish or medaka as a model.  
kiss1 and kiss2 expression in teleost juveniles was reported in both the gonads and the brain of 
developing sea bass (Felip et al., 2009). Another study done on the cobia (Rachycentron 
canadum) reported expression of gpr54-1 at larvae 24 hours post hatching (Mohamed et al., 
2007).  
The expression profile of both kiss1 and kiss2 has been investigated in zebrafish embryonic 
development (Kitahashi et al., 2009; Zhao et al., 2014), and expression was detected in the 
brain already at the first stage investigated, at 24 hours post fertilization (30 somite stage), 
which equals the developmental stage 28 in medaka embryos. Earlier stages were excluded in 
these studies. The expression increased by each day in the time interval 1-7 days post 
fertilization, before a marked increase was seen at 30 days post fertilization, with this level 
remaining high during the adult stages. This expression pattern resembles those found in 
rodents, described in the previous chapter.  
A recent study in zebrafish has investigated the effectiveness of the kiss ligands on GnRH 
neuron development during embryogenesis (Zhao et al., 2014). They found that both Kiss1 
and Kiss2 had a stimulatory effect on GnRH3 neuron proliferation located in the peripheral 
nervous system, while only Kiss1 ligand stimulation had an impact on the GnRH3 in central 
nervous system. Kiss1 had a stimulatory effect on the number of hypothalamic GnRH3 
neurons developing during embryogenesis, but an increase resulting from high stimulation 
was transient as it did not extend into adulthood. These findings are comparable to the study 
done on mice brain tissue (Fiorini and Jasoni, 2010), previously described, where KISS1 
stimulated both growth and development of GnRH1 neurons. Also seen in this zebrafish study 
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was a stimulatory effect of Kiss1 ligands on the number of synaptic contact points of the 
GnRH neurons (Zhao et al., 2014).  
In 2013 a novel study working on medaka embryogenesis was published (Hodne et al., 2013). 
Both an expression analysis of the kiss system genes through embryogenesis, and a 
knockdown study of the respective genes were performed from the earliest stages. The 
expression analyses were performed on both the kiss ligand genes: kiss1 and kiss2, and both 
the receptor genes: gpr54-chr9 and gpr54-chr17 at specific stages of development, from right 
after fertilization and until hatching. The study revealed that both the kiss ligand genes and 
receptor genes were expressed during the embryonic development, but with different 
expression profiles. The two kiss ligands, in addition to one of the receptors (gpr54-chr9) 
were already expressed right after fertilization. This indicates a maternal provision of mRNA 
for these three genes (kiss1, kiss2 and gpr54-chr9). The zygotic expressions of genes are 
expected to appear after gastrulation, around stage 15 of development. After this time point all 
the four kiss system genes appear to be expressed in this species. Regarding the expression 
pattern of the two kiss genes, both showed a rapid increase in expression level at the switch 
between maternally and zygotic kiss expression, with a peak of expression level around stage 
19. The rapid increase in kiss expression coincides with the time right after neurulation offset. 
The kiss receptor paralog gpr54-chr9 was proven to be expressed through the whole study at 
relatively high expression levels, with a peak at the earliest stages, before it declined and 
stabilized around the offset of zygotic expression. The other receptor paralog was not 
detectable before the zygotic transcription offset, but from then on the expression levels 
increased throughout the study.  
A series of knockdowns of the kiss system genes in medaka were then performed (Hodne et 
al., 2013), to investigate the gene functions during embryogenesis, and to reveal any 
functional differences of the maternally provided genes. Knockdown of maternally provided 
kiss1 or gpr54-chr9 resulted in developmental arrest right before gastrulation (stage 11-12). 
At these specific stages the embryonic cells normally start to divide asynchronously, and cell 
migration begins. Therefore it seems that the function of the maternally provided kiss system 
transcripts is closely linked to the initial embryonic cell migration, which is vital for further 
embryogenesis beyond this step. Further, partial knockdowns were performed, leading to 
embryo development past the gastrulation. This gave rise to embryos suffering from reduced 
eye and brain development. kiss2 knockdown of any kind did not result in any increased 
mortality or morphological effects like seen in the kiss1 and gpr54-chr9 knockdowns. Gpr54-
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chr17 knockdown showed no abnormal phenotype until the transitional stage between 
maternal and zygotic provision of transcripts. This correlates with the pattern found in the 
expression analyses. At this point the developmental pathway was clearly affected and the 
embryos died before stage 17. During partial knockdown the development proceeded beyond 
this but the effect on the development of the cranial and brain area was severe, and it is 
therefore likely that the zygotic gene expression of this gene is vital for these developmental 
events. 
A recent KO study performed in zebrafish (Tang et al., 2015) showed some rather 
contradictory results to the study of Hodne et al. (2013). In the zebrafish study it was clear 
that knocking out either of the kiss system genes did not give any drastic morphological 
effect, as the offspring develops normally into adulthood in the KO lines. But a notable 
difference between these studies (apart from different species studied) is that Hodne et al. 
(2013) performed a knockdown of the kiss system genes, preventing translation of the current 
transcripts, while Tang et al. (2015) performed a KO of the respective genes, interrupting the 
current gene and rendering it inoperative. KO of genes could activate compensatory 
mechanisms, which may not be the case in knockdown studies. This means that KO could 
lead to kiss system gene compensation by other neuropeptide -or neurotransmitter/receptor 
systems.  
When comparing the results found in medaka and zebrafish, it is clearly a lot of functional 
differences in the role of the kiss system in early development. Regarding the kiss gene 
expression profiles (described above), variation is found between the two species, with the 
zebrafish expression patterns more resembling those found in rodents. The medaka expression 
level is lower and more stable in comparison, when comparing the stages in the same interval 
of development. The early embryonic expression found in medaka is not comparable with 
zebrafish because of lack of data in zebrafish. Also the many differences revealed when 
comparing these two teleost species emphasize the importance of looking at more than one 
model in studies aimed to reveal gene function, and the diversity seen suggests that the kiss 
system has a varied potential in influencing embryogenesis.  
In summary, the studies performed in teleost species show that, like in mammals, the kiss 
system genes are expressed at early stages where they exert some sort of function in the 
developing embryo. In medaka, studies indicate that the kiss system might exert some 
function in the initial embryotic cell migration at early stages, and is essential for proper brain 
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development. In zebrafish there are studies indicating an early influence of Kiss1 ligands on 
the developing GnRH neurons, probably as a way of shaping the reproductive pathway.  
1.5 In situ hybridization 
In situ hybridization (ISH) is a method that allows specific nucleic acid sequences in the 
cytoplasm to be detected in morphologically preserved cells, tissue samples or whole embryos 
(Thisse and Thisse, 2008). An antisense probe, complimentary to the endogenous RNA of 
interest are used to reveal the spatial expression pattern (Gasnier et al., 2013). Radiolabeled 
probes were first used to detect expression before in situ procedures using nonradioactive, 
hapten-conjugated probes became available. Both are classical ISH methods, where probe 
detection is achieved by chromogenic substrates, visible in the light microscope or in a 
fluorescent microscope. Hapten-conjugated probe detection by chromogenic substrates is 
proven to be a sensitive detection method, giving a clear response if expression is present, 
even at small levels. A clear limitation of this technique is that it lacks any three-dimensional 
visualization possibilities, and multiple-color ISH detection is difficult (Lauter et al., 2011). 
These techniques are now gradually being replaced by the use of fluorescent labeled probes 
(Fluorescent ISH, FISH), a method that overcomes these limitations when combined with 
confocal microscopy imaging. This gives great resolution that enable visualization of specific 
RNAs from the whole tissue and down to a single cell (Gasnier et al., 2013). FISH is a less 
sensitive than classical ISH, but the sensitivity greatly increases when it is combined with a 
signal amplification step by the use of peroxidases in combination with fluorescent tyramide 
substrates in tyramide signal amplification FISH (TSA FISH).  
TSA FISH also utilizes hapten-conjugated probes, specific for the cytoplasmic RNA of 
interest (Gasnier et al., 2013). When synthesizing a hapten-conjugated probe the sequence of 
choice should preferably be more than 1 kb in size, and match a unique sequence in the 
genome to enable highly specific hybridization. The synthesized antisense probe is then set to 
hybridize to the complementary cytosolic RNA in the sample of choice. The hapten conjugate 
on the hybridized probe is then recognized by specific antibodies coupled to a peroxidase 
(Gasnier et al., 2013). Peroxidase is important for the TSA step of the method, by promoting 
precipitation of tyramide components at the adjacent area. The peroxidases work by 
catalyzing the conversion of tyramide molecules into highly reactive free radicals in the 
presence of hydrogen peroxides (Krieg and Halbhuber, 2010). The tyramide free radicals bind 
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covalently to adjacent proteins. In the tyramide components, tyramides are linked to 
fluorophores so that precipitation of tyramide components will lead to aggregation of 
fluorescent molecules, thereby increasing the resulting fluorescent signal. In this way the TSA 
will amplify the expression signal so that even small levels of expression, undetectable by 
regular FISH, could be revealed. 
 
Figure 5. Mechanisms of fluorescent in situ hybridization with tyramide signal amplification; TSA FISH. 
Designed probes hybridizes to the complementary target mRNA. Peroxidases are brought in by antibodies 
specific to the probe marker (here showed as DIG). Tyramide activation by the peroxidases. Aggregation of 
activated tyramides at the area of target mRNA. Ab, antibody; DIG, digoxigenin; HRP, horseradish peroxidase; 
T; tyramides. Figure modified from PerkinElmer webpage: In situ hybridization with TSA; 
http://www.perkinelmer.com/resources/technicalresources/applicationsupportknowledgebase/tsa/ish.xhtml 
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1.6 Aims of the study 
In this study, I have investigated the spatial gene expression of the kiss receptor, gpr54-chr9, 
in medaka. The work was separated into three defined aims: 
The first aim of the study was to set up a fluorescent in situ hybridization (FISH) assay with a 
functional antisense probe for the medaka kiss receptor gpr54-chr9. The FISH protocol was 
originally optimized for zebrafish, so this included setting up an assay in our lab that worked 
in medaka. The first aim also included validation of the specific probe for gpr54-chr9 by 
comparing the labelling with previously published expression maps for gpr54-chr9 in adult 
medaka brain.  
The second aim of the study was to optimize the FISH method to work in embryonic medaka, 
using the validated probe. This was to be followed up by a spatial-temporal expression 
analysis of gpr54-chr9 expression pattern through medaka embryogenesis, to map the exact 
location of the expression during early development at different embryonic stages.  
The third aim was to establish two working labelling approaches, to develop a double-FISH 
assay in the medaka embryo.   
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2 Materials and methods 
All chemicals used were purchased from Sigma-Aldrich (St. Louis, MO, USA), unless 
otherwise stated.  
2.1 Experimental animals 
2.1.1 Medaka 
Fish of the wildtype medaka (Oryzias latipes) dr-R strain were maintained at the University of 
Oslo aquarium facilities on a 14:10-hour light/dark cycle at 27-28 °C. They were fed live 
nauplii larvae of brine shrimp (Artemia franciscana, Argent Laboratories, WA, USA) and dry 
feed (Special Diets Services, UK) 3-5 times per day. The experimental procedures and 
housing were approved by the Norwegian Animal Research Authority.  
2.2 Preparation of samples for in situ hybridization 
2.2.1 Embryos 
Medaka fertilized eggs were harvested for the embryo expression analyses. Right after 
fertilization, female fish with eggs attached to their abdomen were netted and their eggs were 
harvested and transferred to a dish with E3-medium (Appendix IV). The eggs were stored at 
28 °C in an incubator until the right embryonic stage was reached (Iwamatsu, 2004) (Table 2).  
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Table 2. Embryonic stages in focus.  
Embryonic stage Approximate age 
2-3  1 hpf 
8-9  5 hpf 
15 17 hpf 
16 19 hpf 
17 21 hpf 
18-19 23 hpf 
20 28 hpf 
21 32 hpf 
22 36 hpf 
26 2 dpf 
30 3 dpf 
33 4 dpf 
35 5 dpf 
36 6 dpf 
37 7 dpf 
38 8 dpf 
39 9 dpf 
40 > 9dpf 
hpf, hours post fertilization; dpf, days post fertilization.  
 
When the embryos stored in the incubator reached the preferred age, they were fixed in 4 % 
paraformaldehyde, PFA (Electron microscopy sciences, PA, USA) in PBST (0.1 % Tween in 
PBS; Fisher Scientific), and stored over night at 4 °C with rotation.  
After fixation, the eggs were dechorinated under a binocular using fine tweezers, and the 
released embryo was transferred to PBST solution. During dechorination the embryonic stage 
was confirmed by observation in the binocular. 
To prepare the samples for storage, dechorinated embryos were dehydrated by adding an 
increased percentage of alcohol solution (methanol) to the embryonic samples, 25, 50, 75, and 
2× 100 %, each step with 10 min incubation time. After dehydration the embryos were stored 
at -20 °C until usage.  
2.2.2 Adult brains 
Fish were collected for in situ hybridization experiments on adult brains. Male adult fish at 
approximately same size and with an age span of 3-4 month, all assumed to be sexually 
matured based on their age, were netted and transferred to a separate tank. All fish appeared 
healthy. The fish were anesthetized with buffered MS-222 solution (approximately 1 g/L MS-
222 and 1 g/L NaHCO3). Full anesthetization was ascertained before any procedures took 
 32
 
place, by observing behavioral changes (loss of equilibrium) and lack of reaction when 
pinching the tailfin. 
Fully anesthetized fish were transferred to a paper bed soaked in water under a binocular kept 
in the fume hood, for perfusion with fixation solution. The beating heart was located, and the 
thorax was opened using a scalpel so that the heart was exposed. A glass capillary needle, 
coupled to a 2 mL syringe by a narrow plastic hose was used to inject 4 % PFA in PBST into 
the heart. The PFA solution was slowly injected into the beating heart to exchange the total 
blood volume of the fish with the fixation agent. The perfusion proceeded after the heart 
stopped, until the heart turned white and the gills lost its color. The skull roof of the perfused 
fish was opened to allow easier entry of the fixation solution into the brain, and the fish was 
transferred to a tube containing fixation agent of 4 % PFA in PBST, and incubated over night 
at 4 °C with rotation. 
After fixation the perfused brain was carefully dissected out of the fish. First, the fixated fish 
were thoroughly washed with PBS to get rid of the PFA, and kept under the ventilating hood. 
The brain dissection was carried out under a binocular with tissue submerged in PBS. The 
brain was transferred to a tube containing PBST and stored at 4 °C until dehydration.  
Perfused brains were dehydrated by adding an increased percentage of alcohol solution 
(methanol), 25, 50, 75 and 2× 100 %, each step with 10 min incubation time. After 
dehydration the brains were stored at -20 °C until usage.  
2.3 Probe preparation for Fluorescent in situ 
hybridization 
2.3.1 Cloning of plasmids 
The probe used in this work was synthesized from the medaka kiss receptor sequence gpr54-
chr9 with RNA polymerases. This probe was complementary (antisense) to the mRNA of 
interest. To be able to synthesize this probe, the sequence was cloned into an expression 
vector, between specific promoters for the RNA polymerases.  
Because there are some confusion and disagreements about the nomenclature for the genes 
coding for kiss receptors in medaka (see Introduction, and Table 1), we chose to name the two 
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medaka receptors after the chromosome locations of the genes, gpr54-chr9 and gpr54-chr17 
(gene location on chromosome 9 and 17, respectively). The coding sequence of the medaka 
kiss receptor gene, gpr54-chr9, was found in GeneBank at NCBI (XM_004072255.1). This is 
identical to the receptor named Kiss1rb on Ensembl (ENSORLT00000002103), medaka 
GPR54-2 in Pasquier et al. (2012a), Medaka #1 and GPR54-1 in Lee et al. (2009) and gpr54-1 
in both Hodne et al. (2013) and Kanda et al. (2013).  
A vector (pUC57) containing the coding sequence of the receptor gene was ordered from 
GeneScript (Figure 6 and Appendix I). The received plasmid was delivered as dried material 
and was dissolved in nuclease free water (Invitrogen) and stored at -20 °C.  
 
Figure 6. pUC57 plasmid with inserted sequence. The ordered plasmid pUC57 (GeneScript) included the 
insert of the kiss receptor gene gpr54-chr9 from NCBI’s GeneBank (XM_004072255.1). The two gene-specific 
primers (F and R) binding within the inserted gene sequence were: gpr54-ol-49-F and gpr54-ol-1066-R. Figure 
modified from pUC57 protocol (GeneScript).  
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To amplify the sequence that we wanted to use for probe synthesis, a PCR with primers 
specific for a part of the gpr54-chr9 sequence was performed with 5 ng/µL of the pUC57 
plasmid as template. The gene-specific primers for gpr54-chr9 were designed in the program 
Primer3, and ordered from Thermo Scientific. The primer sequences were (F, forward; R, 
reverse primers):  
F: Gpr54-ol-49-F (5’- TGC AAC CTT TCC CTG GAG AT -3’)  
R: Gpr54-ol-1066-R (5’- CTT CTC CTT TGG GTG GTT GC -3’)  
The PCR was performed with Platinum Taq DNA Polymerase according to the manufacturers 
protocol (Invitrogen) and ran on GeneAmp PCR system 2700 (Applied Biosystems, USA). 
The following PCR program was applied: 94 °C for 2 min (initial denaturation), and then 35 
cycles of 94 °C for 30 s (denaturation), 58 °C for 30 s (annealing), and 72 °C for 80 s 
(extension), followed by a prolonged extension at 72 °C for 2 min at the end of the last cycle.  
The size of the PCR product was analyzed by agarose gel electrophoresis. Five µL of the PCR 
product was loaded on a 1 % agarose gel and the migration of the bands was compared to the 
1 kb+ ladder from Invitrogen. The PCR product which gave the expected length of 1017 bp 
(the number of base pairs between the selected primers (R ÷ F = 1066 bp ÷ 49 bp)) was used 
in the following procedures.  
2.3.2 Sequence ligation 
The PCR product was ligated into a pCRII vector (Invitrogen) which contained T7 and SP6 
RNA polymerase promoters on each side of the insertion site (Figure 7). A ligation mix was 
made according to the manufacturer’s protocol, with 1 µL PCR product added to the ligation 
reaction.  
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Figure 7. pCRII plasmid with inserted sequence. Ligation of the linearized sequence resulting from PCR of 
pUC57 into a pCRII vector (Invitrogen), between the promoters of T7 and SP6 RNA polymerase. These 
promoters are already present in the vector, and flanked by M13F (forward primer) and M13R (reverse primer). 
Also included in the pCRII vector were an ampicillin resistant gene, and a LacZ gene which includes the 
multiple cloning site of the vector. Figure modified from pCRII protocol (Invitrogen).  
 
2.3.3 Transformation 
The plasmid resulting from the ligation reaction was used for heat shock transformation of E. 
coli bacteria following the manufacturer’s protocol (One Shot TOP10 Chemically Competent 
E.coli, Invitrogen), to mass produce the ligated vector. One hundred µL of the transformed 
bacteria was plated out on LB plates containing ampicillin (100 µg/mL) and X-gal (50 
µg/mL; Promega), for screening of transformants. An ampicillin resistant gene present in the 
pCRII vector ensures the growth of only transformed bacteria. The X-gal is added to enable 
blue/white screening. The multiple cloning site of the plasmid is positioned inside the LacZ 
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gene sequence of the plasmid, thus inactivating LacZ upon insertion. Thereby, the bacteria 
that have been transformed with a plasmid containing an insert will turn out white since the 
insertion leads to a dysfunctional -galactosidase. The bacteria that have been transformed 
with an empty plasmid turn out blue, since the X-gal produces a distinctive blue color dye 
when cleaved by a functional -galactosidase enzyme.  
Five colonies of successful transformants from each plate were grown in LB-medium and the 
plasmids were purified with a Midiprep kit according to the protocol of the manufacturer 
(Wizard Plus Midiprep DNA purification system kit, Promega). The concentration of the 
plasmid solution was measured by NanoDrop, ND-1000 Spectrophotometer (Thermo Fisher 
Scientific, Waltham, MA USA), and the purified plasmids were sent for sequencing at 
Eurofin Genomics (Ebersberg, Germany). The sequenced plasmid was found to have the 
correct sequence inserted in the plasmid, as the sequence was comparable to the NCBI gene 
bank sequence (see aligning in Appendix II). In addition, sequenced cDNA from the fish used 
in the experiments were aligned with the sequence ordered from GeneScript, and were proven 
to be similar (not shown). One plasmid with the gpr54-chr9 sequence inserted was chosen and 
used in subsequent steps. 
2.3.4 Probe linearization and amplification 
To linearize and amplify the sequence before producing the probe, a PCR was performed with 
10 ng/µL of the plasmid from Midiprep as a template using M13F and M13R primers 
(Invitrogen), flanking the two RNA polymerases (SP6 and T7) in the pCRII vector, see Figure 
7. The PCR was performed with Platinum Taq DNA Polymerase according to the 
manufacturers protocol (Invitrogen), and ran on GeneAmp PCR system 2700. The following 
PCR program was applied: 94 °C for 2 min (initial denaturation), and then 35 cycles of 94 °C 
for 30 s (denaturation), 55 °C for 30 s (annealing), and 72 °C for 1 min and 50 s (extension), 
followed by a prolonged extension at 72 °C for 2 min at the end of the last cycle.  
The size of the PCR product was analyzed by agarose gel electrophoresis. Four µL of the 
PCR product was loaded on a 1 % agarose gel and the migration of the bands was compared 
to the 1 kb+ ladder from Invitrogen. The PCR product which gave the expected length of 
1258 bp (length of insert (1017 bp) + length from M13R to insert site (130 bp) + length from 
insert site to M13F (111 bp) = 1258 bp) was used in the following procedures.  
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2.3.5 Probe synthesis 
Synthesis of the receptor probe was performed by in vitro RNA transcription with the PCR 
product as template and SP6 or T7 polymerases from Promega. Antisense RNA transcript was 
made by transcription by T7 RNA polymerase, giving a probe sequence of 1215 bp (length of 
linearized PCR product (1258 bp) ÷ distance from M13F to T7 promoter (43 bp) = 1215 bp). 
Hapten-conjugated UTP’s: DIG or FITC was added into the transcription mixture and 
incorporated into the RNA probe by transcription. A transcription mix was made according to 
the manufacturer’s protocol, with a total volume of 40 µL: 4 µL PCR product, 8 µL 
transcription buffer, 4 µL RNA labelling mixture (DIG/FITC, Roche Life Science) including 
NTPs, 1 µL RNAsin plus (Roche Life Science), 4 µL DTT (100 mM; Roche Life Science), 4 
µL RNA polymerase T7 (20 u/µL; Promega) and nuclease free water until total volume was 
reached. The reaction was incubated at 37 °C for two hours. This resulted in single stranded 
copies of labelled RNA sequences in the form of antisense probes, that hybridizes with target 
mRNA upon in situ hybridization.  
As a negative control during the experiments, the sense probe was also generated by 
following the same protocol, except that sense probe was made with SP6 RNA polymerase 
instead. 
2.3.6 Probe purification 
Purification of the synthesized probes was done with the Nucleospin RNA clean-up kit 
(Macherey-Nagel) and performed according to the protocol given by the manufacturer, with 
the exception of the elution step which was performed directly in deionized formamide. In 
short, a specific buffer that binds the sample RNA to a nucleoSpin column was added to the 
sample. The bound RNA were then washed and dried for 3 min, before the RNA was eluted 
by nuclease free water into a tube containing deionized formamide. The probes were stored at 
-20 °C.  
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2.4 Control experiments 
2.4.1 Probe validation 
Because in situ hybridization of gpr54-chr9 has not been previously performed in embryonic 
medaka, the probe was first used to map the expression of gpr54-chr9 in adult brain from 
male medaka fish, to compare the expression pattern with already published data (Kanda et 
al., 2013).  
2.4.2 Positive controls 
A positive control was included in each in situ hybridization experiment on embryo to ensure 
the success of each run. The positive control was a probe that hybridizes to the mRNA of the 
CXC motif chemokine receptor 4a (cxcr4a), which is seen to give a characteristic expression 
pattern in 1.5 dpf medaka embryos.  
2.4.3 Negative controls 
To ensure that the probe did not bind to unspecific mRNAs in the samples, negative controls 
were included in the experiments by running in situ on samples added sense probes. The sense 
probe is identical to the target mRNA, and should therefore not hybridize to the target mRNA. 
Sense controls were run on both brain and embryo samples.  
Samples added no probe at all, and samples added probe, but no tyramide components (signal 
amplificator and carrier of fluorphore dye, described later) were also used as negative controls 
during the experiments, and were included in each in situ run.  
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2.5 Expression analyses with fluorescent in situ 
hybridization: single-, double- or triple- FISH 
Fluorescent in situ hybridization by tyramide signal amplification was used as a method to 
reveal the expression pattern of the gpr54-chr9 gene (see Introduction). In cells expressing 
this kiss receptor the synthesized probe will hybridize to the target mRNA, enabling targeted 
detection. This method also enables multi-labeling of the sample by adding more than one 
probe. Single- or double FISH can be performed by adding one or two different RNA probes, 
respectively. For each additional probe added, the total time of the FISH method increases 
with one day, so that the total method last for 3 or 4 days. The number of possible probes was 
limited to the available tyramides, which in our case was two: FITC and TAMRA.  
The method was optimized from a protocol received from our collaborators in the group of 
Philippe Vernier at the Institute of Neurobiology Alfred Fessard, CNRS Gif-sur-Yvette, 
France, working on in situ hybridization on zebrafish, to fit our medaka model. The detailed 
optimized protocol is found in Appendix VI.  
In situ hybridization was run on insituPro VSi robot (Intavis Bioanalytical Instruments, 
Germany), controlled by the InsituPro VSi operation software. During the in situ the tissue 
samples were placed in a gridded well, and the well was placed in one of the chambers on a 
plate in the in situ robot. Several embryos or brains can be placed in the same well; the 
number depends on the amount of fluid added. It was crucial for the result that all the tissue 
samples were embedded in fluid at all time.  
Before in situ hybridization the prepared samples, embryos or brains, were rehydrated by 
gradually decreasing the alcohol percentage of the incubation solution (ethanol), 100, 75, 50 
and 25 %, with 10 min incubation time per step. In situ hybridization was performed on 
rehydrated embryo samples in the embryo expression analyses, and performed on rehydrated 
brain samples from male adult medaka fish during the probe validation analyses.  
The samples were washed in PBST, before they were treated with proteinase K. The added 
proteinase K enzyme will digest the tissue by the cleavage of specific peptide bonds, so that 
the reagents used in the experiment will more easily penetrate the tissue. The type of 
treatment was dependent of the sample type (embryo or adult brain), and in the case of 
embryo samples it was dependent of the embryonic stage. Different proteinase K treatments 
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were tested, based on two different protocols received from other labs (Table 3). Proteinase K 
treatment was terminated by incubation in 20 mM glycine, before the samples were washed in 
PBST.  
Table 3. Guideline of PK treatment of the samples.  
Embryonic stage [PK] treatment Time of PK 
treatment (min) 
Treatment 
temperature 
Protocol’s origin 
<18 None 0 - A and B 
18-19 25 µg/mL  
1-2.5 µg/mL 
5 
20 
RT 
37°C 
A 
B 
26 25 µg/mL  
2.5-5 µg/mL 
10 
20 
RT 
37°C 
A 
B 
30 25 µg/mL  
10 µg/mL 
30 
20 
RT 
37°C 
A 
B 
33 25 µg/mL  
10 µg/mL 
40 
20 
RT 
37°C 
A 
B 
35 25 µg/mL  
20 µg/mL 
40 
20 
RT 
37°C 
A 
B 
36 25 µg/mL  
40 µg/mL 
40 
20 
RT 
37°C 
A 
B 
37-39 25 µg/mL  
60 µg/mL 
40 
20 
RT 
37°C 
A 
B 
Whole adult brain 25 µg/mL 60 RT A 
A guideline of the PK treatment in embryos and brain samples. The treatments were recommended by 
collaborators from two different groups A and B. Both groups works with medaka as a model organism. A=The 
group of Jean-Stéphane Joly, CNRS Gif-sur-Yvette, France. B=The group of Kataaki Okubo, University of 
Tokyo, Japan. PK treatment, Proteinase K treatment.  
 
Subsequently, the samples were prehybridized with Hybridization mix (HybMix; see 
Appendix III) for 4 hours at 65 °C. The HybMix was replaced with a solution of the probe of 
interest diluted in HybMix solution. This dilution had to be optimized for each probe and 
differed between brain and embryo samples. The probes were denatured by 90 °C heat shock 
(10 min) before addition to generate single stranded RNA that easily could hybridize with the 
complementary target mRNA. When multi-labelling of the sample was done, all the probes 
were added at once. The added probe/probes were left to hybridize to the target mRNA 
overnight (minimum 15 hours) at 65 °C.  
In the second day of in situ the samples were added several prepared buffers, one at the time, 
to rinse the samples so that excess probe was washed out. All buffers were preheated to 65 
°C. First, the samples were added a Hybridization wash solution (HybWash; see Appendix 
III), secondly they were added an increasing amount of 2× SSC (25, 50, 75, and 100 %) 
diluted in HybWash, before the solution was replaced by 0.2× SSC (100 %). The temperature 
was lowered to RT, and the samples were washed in PBST. Endogenous peroxidases in the 
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samples were inactivated by adding 2 % H2O2 (in PBST) with 30 min incubation time at RT. 
This prevents the activity of naturally occurring peroxidases in further steps. Then the 
samples underwent a thorough PBST wash, before 2 hours of blocking using 1:10 blocking 
reagent (Roche Life Science) in maleic acid buffer (MAB; see Appendix III). Blocking was 
performed to prevent unspecific binding. After blocking, the antibody specific to the probe 
used was diluted in blocking buffer and added to the samples (1:150 anti-DIG-peroxidase 
(anti-DIG-POD; Roche Life Science) or 1:200 anti-FITC-POD (Roche Life Science) in 
blocking buffer; blocking reagent + MAB). The antibodies used are linked to POD, which is 
important for highly specific tyramide activation and fluorophore aggregation in the 
upcoming steps. During multi-labelling, one specific antibody is added per day to enable 
detection of each probe - one after the other. The added antibody was incubated overnight at 4 
°C with rotation.  
At the third day of in situ, excess antibodies were washed out of the samples by PBST before 
the tyramide substrate of choice was added (tyramide-fluorophore component; 1:100 tyr-
TAMRA or 1:200 tyr-FITC, together with 0.003 % H2O2 in PBST) and incubated, see 
Appendix V for tyramide synthesis. The incubation times of the different tyramide substrates 
depended on the type of fluorophore coupled to the tyramide (tyr-TAMRA, 45 min or tyr-
FITC, 30 min). In the resulting process, the POD on the antibody will activate the tyramides, 
causing the tyramide components to precipitate, and thereby aggregating fluorophores at the 
place of antibody-POD binding, which is the area expressing the gene of interest. Areas with 
no antibody binding will not have activated tyramides. The excess tyramides were washed out 
with PBST, before a bleaching reagent was added in the form of 2 % H2O2 for 1 hour to 
inactivate the added PODs. After POD inactivation the samples were thoroughly rinsed with 
PBST in several steps, and in the case of single FISH staining the method was finished at this 
step. In the case of double FISH the method continued, by repeating the blocking step, before 
a second antibody incubation overnight. First the blocking buffer was prepared; 1:10 blocking 
reagent in MAB buffer, and added to the samples with 1 hour incubation time. After blocking, 
the antibody specific to the second probe was diluted in blocking buffer and added to the 
samples manually (1:150 anti-DIG-POD or 1:200 anti-FITC-POD in blocking buffer; 
blocking reagent + MAB). The added antibody was incubated overnight at 4 °C with rotation.  
The fourth day of FISH was only required for double FISH, and consisted of adding a second 
tyramide substrate to label the areas of antibody binding from the day before. After a wash in 
PBST to remove excess antibodies, the samples were added the tyramide substrate of choice - 
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which had to be different from the first tyramide added (tyramide-fluorophore component; 
1:100 tyr-TAMRA or 1:200 tyr-FITC, together with 0.003 % H2O2 in PBST). The added 
tyramides were incubated for 45 or 30 min, depending on the type of fluorophore coupled to 
the tyramide, tyr-TAMRA or tyr-FITC respectively. The excess tyramides were washed out 
with PBST, before a bleaching reagent was added in the form of 2 % H2O2 for 1 hour to 
inactivate the added PODs. The hydrogen peroxide was washed out by PBST, and after this 
PBST rinsing the sample labeled with double FISH is ready.  
Following in situ hybridization, embryo and brain samples could be stored at 4 °C for shorter 
periods of time (couple of days) before proceeding with the experiments.  
2.6 Sample preparation for confocal microscopy 
2.6.1 Brain sectioning  
Following in situ hybridization on whole brain samples, the brains were sectioned into slices 
before any subsequent analyses. This was done using a vibratome (Campden instruments 
LTD, UK). The brains were first rinsed in PBS, before excess fluid was removed by fine 
paper, and then embedded in 3 % agarose. Cubes of gel each containing a brain were cut out 
of the gel with a scalpel. The brain cube was then glued in a vertical position (olfactory bulbs 
facing up) onto a plate in a chamber, and once the glue had dried this chamber was filled with 
PBST until the gel cube was completely covered by the fluid. One hundred and fifty µm thick 
transverse sections were made. Each brain section was transferred to a tube containing PBST 
by a fine paint brush. 
2.6.2 DAPI staining 
4’,6-diamidino-2-phenylindole (DAPI) stain (5 ng/mL) was added to each sample (embryos 
or brain sections), before incubation in the dark (using aluminum foil). The incubation time 
for the embryos was 4 hours, while the incubation time for brain sections was 20 min. The 
DAPI will stain the cell DNA, and thus label the cell nuclei. The samples were washed 
repeatedly in PBST afterwards to remove excess DAPI, and stored in PBST at 4 °C until 
imaging with confocal microscopy.  
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2.6.3 Mounting of confocal microscopy samples  
Before confocal microscopy imaging the samples were mounted on slides. For embryos, a 
well was made of donut-shaped stickers added in a stack. An embryo was placed in the 
middle, and the fluid was removed by a filter paper, before drops of glycerol-based 
Vectashield (Vector Laboratories, California, USA) was added to the sample. Vectashield 
gives an ideal refractive index in the microscope, and preserves the samples by preventing 
drying and inhibit photo-bleaching of the fluorochromes. The orientation of the embryo was 
optimized by gently moving the embryo with tweezers under a binocular, before a coverslip 
was added to seal the samples. The DAPI-stained brain sections were mounted on a glass 
slide under a binocular in the right anatomical order, forebrain to brainstem. The excess fluid 
was removed by a filter paper, and Vectashield was added to the specimen before a coverslip 
was added.  
2.7 Confocal microscopy 
The slides were analyzed by confocal microscopy (Zeiss LSM 710, Germany) with proper 
lasers (argon) depending of the kind of fluorescent labels used in the experiment. The settings 
were adjusted on the computer (Zen 2009 software). The 10× (air) objective was used to get 
an overview of the sample, and the 20× (air), 25× (water) and 40× (oil or water) objectives 
was used to achieve more detailed images. In the brain sections, the pattern of expression in 
each area of the brain was compared with published expression maps of kiss receptor gpr54-
chr9 in the medaka brain (Kanda et al., 2013). In addition, the medaka brain atlas published 
by Ishikawa et al. (1999) was used in this process for correctly orientation in the brain. Z-
stacks of confocal images were made, enabling three-dimensional expression patterns to be 
revealed. Expression was observed as fluorescent color (FITC/TAMRA) aggregating around a 
cell nucleus colored by DAPI. The quantity of color around each nucleus indicates the 
expression level of that cell, with low expression having a dotted appearance around the 
nuclei.  
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Table 4. Confocal microscopy argon lasers.  
Lasers used during confocal microscopy: 
Type of staining: Laser , nm: Visible color added to laser: 
DAPI 405 Gray 
FITC 488 Green 
TAMRA 561 Red 
Information of the different lasers tuned on to reveal the different types of staining, DAPI and tyramides: 
FITC/TAMRA.  
2.8 Confocal image analyses 
The Z-stacks of images from the confocal microscope were analyzed in the ImageJ-based 
program Fiji (http://fiji.sc/Fiji). The stacks of images taken of the expression in adult brain 
were sorted on the computer, and similar brain areas were aligned to compare the expression 
patterns. Similar areas from the positive and negative control samples were included in this 
comparison. The stacks of images taken of the embryonic expression were sorted on the 
computer by the embryonic stage, and the expression pattern in each stage was noted, and 
compared with the embryonic control samples. 
The images shown in Results, were representatives for the average expression pattern seen. 
Images were made by fusing Z-stacks, fusing the stacked images together to a single picture. 
Further, by splitting and fusing the different colors used, it is possible to look at both each 
color (DAPI/FITC/TAMRA) on its own, or together. The light settings and contrast were 
optimized in each picture, before composites were assembled using PowerPoint.  
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3 Results 
3.1 Fluorescent in situ hybridization method adaptation  
The fluorescent in situ hybridization (FISH) method was adapted from zebrafish to medaka 
(embryo and adult brain) by repeated trials. Different variables were tested in these trials, and 
the different outcomes were assessed.  
Through these trials it was found that the in situ robot had an optimal volume of 200 µL per 
sample well for all solutions, and working with volumes different from this was not 
successful. Two hundred µL was enough to cover the samples, smaller volumes increased the 
risk of drying of the samples, while increased volumes (300 µL tested) resulted in a decreased 
precision of the robot, as it failed to keep the volume distributions constant. Using this sample 
well volume, it was found that the optimal sample size was 1-2 brains per well, or 1-15 
embryos. In addition, it was clear that the standard wells used for the brain samples had a 
mesh that were too coarse for the earliest embryonic stages (mesh size 100 µm), damaging the 
tissue during fluid exchange. This improved when using wells with a finer mesh (mesh size 
55 µm). It was further found that the robot worked best with a low number of wells. The robot 
goes through a series of cleaning steps between every well to avoid contamination. These 
steps are time-consuming, giving that each additional well increases the incubation time in 
that step. In addition, increased number of wells sometimes led to inaccurate volume 
exchange distributed by the robot. The ideal number of wells was found to be less than 15 
when working on the current protocol.  
The proteinase K treatments tested was based on values obtained from protocols received 
from two separate groups (see Materials and methods, Table 3); the group of Jean-Stéphane 
Joly, CNRS Gif-sur-Yvette, France, and the group of Kataaki Okubo, University of Tokyo, 
Japan. Whole brain proteinase K treatment was tested with the given concentration, but 
different incubation times (the stated 60 min, and 45 min). Whole brains were found to 
tolerate a one hour long proteinase K treatment of 25 µg/mL at room temperature, without 
substantial tissue damage. This optimal proteinase K setting was similar to the one in Joly’s 
protocol. Medaka embryos were found to be much more fragile, and most of the settings in 
the received protocols were found to be too harsh. But through a series of trials it was found 
that Okubo’s settings worked well when the reaction temperature was reduced. In this way, 
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embryos of different stages were added various concentrations of proteinase K according to 
protocol, with younger stages receiving a more diluted enzyme. The incubation time was 20 
minutes for all stages, but the reaction was carried out at room temperature, not at 37° C.  
When running in situ hybridization on whole brains, an optimal probe concentration of 10 µL 
gpr54-chr9 probe per 200 µL total well volume was established after several trials. Decreased 
concentrations gave no signal or a reduced signal, and increased concentrations gave greater 
background staining. Because I did not achieve any specific gpr54-chr9 labeling in the 
embryonic samples, no optimal embryonic probe concentration was established 
To decrease background staining of the samples, additional washing steps was included after 
the antibody incubation and after tyramide-compound activation. The peroxidase inactivation 
step by hydrogen peroxide (2 %) after tyramide-compound incubation was increased from 30 
min to 60 min to decrease the background staining and to avoid cross-reactivity of the two 
different labelings when running double FISH. Effective peroxidase inactivation is crucial 
between the two labeling procedures to avoid false positive signal overlap of the two probes.  
These adjustments to the original protocol were found to give a clearer expression signal, 
and/or increasing the background staining, improving the detectability of the FISH method.  
3.2 Expression analyses by fluorescent in situ 
hybridization 
Gene expression in the samples was explored under the confocal microscope by scanning 
through the sample. Expressing cells were seen as spots of fluorescent color surrounding a 
DAPI-colored cell nucleus. Some of the cells were marked brightly by fluorescence, in 
addition to an unusually strong DAPI color. These cells were evenly spread out through the 
brain, some of them oriented in chain structures, and they looked different from the 
expressing cells revealed by the antisense probe. Such cells were counted as auto-
fluorescence, and excluded from the analyses.  
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3.2.1 Spatial expression of gpr54-chr9 in adult medaka brain – probe 
validation 
The gpr54-chr9 expression pattern in adult medaka brains were revealed by looking through 
the sectioned in situ labeled brains, from anterior to posterior. After adapting the method, the 
pattern of gene expression of gpr54-chr9 was found consistently in the adult brains tested 
(approximately 15 brains), also between different FISH runs. This made the expression 
patterns presented in the following paragraphs good representatives for the average expression 
pattern seen in the experiments. Further, the expression found showed bilateral symmetry 
around the midline in every area of expression. In addition, every in situ run included negative 
controls (described in next paragraph), giving basis for comparison of the expression pattern 
resulting from the gpr54-chr9 probe to negative control samples. 
When mapping the spatial expression pattern of gpr54-chr9 in adult brain, expression was 
revealed at distinctive brain areas. The most anterior area found to express gpr54-chr9 was 
area ventralis telencephali pars dorsalis (Vd) of the telencephalon (Figure 8). This area is 
found central in the section. The expression appeared as many TAMRA-colored red spots 
clustering around the DAPI nuclei. Further, the expressing cells were dense in certain areas, 
localized along the midline. In the same brain section expression was also found in a more 
ventral part of the telencephalon, close to ventralis telencephali pars lateralis (Vl), lateral on 
either side of the midline (Figure 9). The number of labeled cells was lower compared to what 
was found in Vd, but these cells were large and had a spherical shape, and in addition, the 
cells were found to cluster together in a distinctive manner.  
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Figure 8. gpr54-chr9 expression in Vd. Whole brain in situ with gpr54-chr9 probe, transverse view. A: An 
illustration of the brain section, with the area seen in the confocal pictures marked with a red square. B: Confocal 
Z-stack (24 µm) showing gpr54-chr9 (red) and DAPI (grey). A lot of expression is seen in the central area, 
marked with arrows. The image is a merged image of DAPI (C) and gpr54-chr9 (D). Images taken with 40× oil 
objective. Vd, ventralis telencephali pars dorsalis.  
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Figure 9. gpr54-chr9 expression in ventral telencephalon, lateral of the midline. Whole brain in situ with 
gpr54-chr9 probe, transverse view. A: An illustration of the brain section, with the area seen in the confocal 
pictures marked with a red square. B: Confocal Z-stack (17 µm) showing gpr54-chr9 (red) and DAPI (grey). 
Area with clustered expressing cells marked with arrows, close to Vl area. The image is a merged image of 
DAPI (C) and gpr54-chr9 (D). Images taken with 40× oil objective. Vl, ventralis telencephali pars lateralis.  
 
In the posterior section bright spots of expression were found in the preoptic area (POA) of 
the hypothalamus, with expression seen scattered over the entire area (Figure 10). The 
expressing cells appeared large, with a slightly spherical shape, and many expressing cells 
were present. In the more central parts of the same brain area expression was found in the 
ventralis telencephali pars supracommissuralis (Vs; Figure 11) of telencephalon. The 
expression was dense in this area as well, but the cells appeared smaller in comparison.  
 50
 
 
Figure 10. gpr54-chr9 expression in POA. Whole brain in situ with gpr54-chr9 probe, transverse view. A: An 
illustration of the brain section, with the area seen in the confocal pictures marked with a red square. B: Confocal 
Z-stack (40 µm) showing gpr54-chr9 (red) and DAPI (grey). Arrows marks some of the several expressing cells. 
Large cells were expressing the current gene in this area. The image is a merged image of DAPI (C) and gpr54-
chr9 (D). Images taken with 40× oil objective. POA, preoptic area. 
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Figure 11. gpr54-chr9 expression in Vs. Whole brain in situ with gpr54-chr9 probe, transverse view. A: An 
illustration of the brain section, with the area seen in the confocal pictures marked with a red square. B: Confocal 
Z-stack (32 µm) showing gpr54-chr9 (red) and DAPI (grey). Arrows marks some of the several expressing cells. 
The image is a merged image of DAPI (C) and gpr54-chr9 (D). Images taken with 40× oil objective. Vs, 
ventralis telencephali pars supracommissuralis. 
 
Further, the most posterior gpr54-chr9 expressive areas was found in the nucleus preopticus 
pars parvocellularis (POp) area of the hypothalamus (Figure 12). The expression was seen as 
large cells forming cell clusters, evenly distributed over the entire area. The expression seen 
in POp covered a big area of the ventral part of the section, and proceeded upward to more 
central regions. The expression preceded to the nucleus preopticus pars magnocellularis 
(POm) and ventralis telencephali pars posterior (Vp) areas (Figure 13) in the border between 
the hypothalamus and the telencephalon. Labeled cells were found with high density. Also 
here, some of the expressing cells appeared large in size, but most of the cells were normal in 
size and shape. Several of the expressing cells formed cell clusters in this area.  
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Figure 12. gpr54-chr9 expression in POp. Whole brain in situ with gpr54-chr9 probe, transverse view. A: An 
illustration of the brain section, with the area seen in the confocal pictures marked with a red square. B: Confocal 
Z-stack (22 µm) showing gpr54-chr9 (red) and DAPI (grey). Areas with large, clustering cells showing 
expressing are marked with arrows. Chain of auto-fluorescent cells marked by a triangle. The image is a merged 
image of DAPI (C) and gpr54-chr9 (D). Images taken with 40× oil objective. POp, nucleus preopticus pars 
parvocellularis. 
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Figure 13. gpr54-chr9 expression in POm and Vp. Whole brain in situ with gpr54-chr9 probe, transverse 
view. A: An illustration of the brain section, with the area seen in the confocal pictures marked with a red square. 
B: Confocal Z-stack (24 µm) showing gpr54-chr9 (red) and DAPI (grey). Areas with clustered expressing cells 
marked with arrows. The expression appear dense in these areas. Auto-fluorescent cells marked by triangles. The 
image is a merged image of DAPI (C) and gpr54-chr9 (D). Images taken with 40× oil objective. POm, nucleus 
preopticus pars magnocellularis; Vp, ventralis telencephali pars posterior.  
  
More posterior sections where all screened for gpr54-chr9 expression, but no labelled cells 
were revealed. Special attention was given to the habenula, because previous reports have 
found expression in this area (see Introduction). However, no clear labelling of cells was 
found in this area in my experiments (Figure 14). The habenula often showed some evenly 
scattered coloring, seen on Figure 14, but not clear enough to conclude with any specific 
labeling in this area.  
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Figure 14. No gpr54-chr9 expression in the habenula. Whole brain in situ with gpr54-chr9 probe, transverse 
view. A: An illustration of the brain section, with the area seen in the confocal pictures marked with a red square. 
B: Confocal Z-stack (15 µm) showing possible gpr54-chr9expression (red) and DAPI (grey). No clear cell 
expression was found. Auto-fluorescent cell marked by a triangle. The image is a merged image of DAPI (C) 
and gpr54-chr9 (D). Images taken with 40× oil objective. HB, habenula. 
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3.2.2 Negative controls 
Three wells containing negative control samples were included in all FISH experiments. 
These were experiments on adult brain or embryos with either no probe added, no tyramides 
added, or using sense probes of the gpr54-chr9. When examining at the negative controls 
under the confocal micriscope, settings were kept constant to the values used during the 
expression analyses. The samples added no probe (not shown) showed only auto-fluorescent 
cells, by some bright tyramide colored cells, also brightly lighting up on the DAPI coloring. 
The samples added no tyramides (not shown) appeared dark on the TAMRA/FITC, but had 
similar, bright DAPI nuclei showing up on the images as auto-fluorescent cells. When turning 
up the fluorescent light, the same cells lit up in TAMRA/FITC. In the sense probe testing, a 
sense probe concentration similar to the optimal antisense concentration was used. All brain 
sections in the sense tests were examined for labeling, and no expression similar to those seen 
for the antisense probe was found in any areas. Figure 15 and Figure 16 show two examples 
of sense experiments. The first image (Figure 15) shows the preoptic area (POA), the same 
area as analyzed with the antisense probe in Figure 10. The sense probe gave no specific 
labelling of cells in the POA like seen in the antisense experiments, but some auto-fluorescent 
cells were seen lightened up bright on both TAMRA and DAPI. The second image (Figure 
16) shows the Vs in the telencephalon, which is the same area pictured for the antisense probe 
in Figure 11. Only auto-fluorescent cells were seen here, as the structures labelled with 
TAMRA was also strongly labeled with DAPI. No specific labelling was seen in the Vs.  
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Figure 15. No expression of gpr54-chr9 SENSE probe in POA. Whole brain in situ with gpr54-chr9 SENSE 
probe as negative control, transverse view. A: An illustration of the brain section, with the area seen in the 
confocal pictures marked with a red square. B: Confocal Z-stack (20 µm) showing any gpr54-chr9 SENSE 
expression (red) and DAPI (grey). No expressing cells were found. Auto-fluorescent cells marked by triangles. 
The image is a merged image of DAPI (C) and gpr54-chr9 SENSE (D). Images taken with 40× oil objective. 
POA, preobtic area. 
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Figure 16. No expression of gpr54-chr9 SENSE probe in Vs. Whole brain in situ with gpr54-chr9 SENSE 
probe as negative control, transverse view. A: An illustration of the brain section, with the area seen in the 
confocal pictures marked with a red square. B: Confocal Z-stack (14 µm) showing any gpr54-chr9 SENSE 
expression (red) and DAPI (grey). No expressing cells were found. Chains of auto-fluorescent cells marked by 
triangles. The image is a merged image of DAPI (C) and gpr54-chr9 SENSE (D). Images taken with 40× oil 
objective. Vs, ventralis telencephali pars supracommissuralis. 
  
3.2.3 Spatial expression in medaka embryos  
Potential expression in the in situ labelled embryo samples were inspected under the confocal 
microscope. In addition to the embryos labeled with gpr54-chr9 and the negative controls 
(described previously), a well of positive controls were included in each run.  
The FISH method was established in embryos using the positive control, cxcr4a probe, at a 
concentration of 8 µl per 200 µl total well volume in 1.5 day old embryos. cxcr4a expressing 
cells were found in the same areas as previously found by members of my group 
(unpublished), giving rise to a characteristic expression pattern along the outer edge of the 
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developing retina, following the shape of the eye cavity from an anterior point and further 
posterior to each eye, in the outer area of the brain (Figure 17). The expression was seen as 
bright red spots, colored by TAMRA, each surrounding a nucleus. The edge effect was large, 
seen as strong labeling of the surface of the embryo.  
Despite many trials variating several different parameters in the in situ protocol, the gpr54-
chr9 probe gave no specific labeling in embryos at any stage.  
 
Figure 17. cxcr4a expression in embryo 1.5 dpf. Whole embryo in situ with cxcr4a probe, labelled with 
TAMRA. A: DAPI stained overview image of the embryo, with the area seen in the B-D confocal pictures 
marked with a red square. B: Confocal Z-stack (22 µm) showing cxcr4a (red) and DAPI (grey). Some of the 
expressing cells are marked by arrows. Distinctive expression pattern along the eye cavities. The image is a 
merged image of DAPI (C) and cxcr4a (D). Images taken with 40× oil objective. 
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3.2.4 Double fluorescent in situ hybridization establishment 
To enable double FISH experiments, two separate labelling approaches have to be 
established. Two different hapten-conjugates are needed, one for each probe, and in addition 
two tyramide components have to be established. In this way the two specific probes tested 
for could be labelled separately. Probes labelled with different hapten-conjugates was 
established for the positive control, cxcr4a, with two different working tyramide compounds, 
tyr-TAMRA (red) and tyr-FITC (green). Expression was seen in both cxcr4a-TAMRA 
labeled embryos and cxcr4a-FITC labeled embryos, see Figure 17 and Figure 18, 
respectively. The expression pattern shown by the two different labeling approaches were 
similar, a bilateral expression pattern with labelled cells showing along the outer edge of the 
developing retina, following the shape of the eye cavity from an anterior point and all the way 
back posterior to each of the eyes in the outer area of the brain. The cxcr4a expressing cells 
appeared approximately similar in every successive run, with almost same expression level 
and pattern regardless of the tyramide component used.  
 
Figure 18. cxcr4a expression in embryo 32 hpf. Whole embryo in situ with cxcr4a probe, labelled with FITC. 
The image, is a confocal Z-stack (30 µm) merging cxcr4a (green) and DAPI (grey). Some of the expressing cells 
are marked by arrows. Distinctive expression pattern along the eye cavities and posterior to the eyes at the edge 
of the developing brain. Confocal microscopy imaging with 20× air objective. 
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4 Discussion  
In this study, a fluorescent in situ hybridization (FISH) assay in whole brains from medaka 
has been set up. In addition, antisense probes hybridizing to the mRNA encoding the Kiss 
receptor gpr54-chr9 gene has been successfully made, and the spatial expression pattern in 
the adult brain has been mapped. Two different tyramide labels were established in embryos 
with a positive control probe. However, as I did not see any labeling with the gpr54-chr9 
probe in embryos, the expression pattern of gpr54-chr9 through embryogenesis is still 
unknown. 
4.1 Spatial expression pattern of gpr54-chr9 in adult 
brain 
After adapting the method, gpr54-chr9 antisense probe was found to work in whole brains 
from adult medaka, giving a spatial expression pattern with many similar aspects to the 
expression map found in the literature (see Introduction). Through systematic trials, it was 
found that gpr54-chr9 expression is present in the ventral telencephalon in the anterior part of 
the brain (in Vd, lateral-ventral telencephalon, Vs, and Vp; see Results) and in the ventral 
hypothalamus in the posterior part of the prosencephalon (in POA, Pop and POm; see 
Results). This corresponds with the expression pattern reported in medaka by Kanda et al. 
(2013), except in habenula were no clear expression was detected in the current work (see 
Figure 14, and discussion later in this chapter). This indicates that the adapted protocol is 
working, and that the gpr54-chr9 probe is valid.  
During my experiments, a distinctive difference was observed between the cell appearance 
between the ventral telencephalon and the ventral hypothalamus gpr54-chr9 expressing cells 
(see Results), with the latter showing cell expression in large, slightly spherical shaped cells 
clustering together, while in the former the expressing cells appear smaller and more normal 
shaped, but also showing clustering tendencies. These findings correlates with the findings 
made by Kanda et al. (2013), stating that gpr54-chr9 is mainly expressed by large neurons in 
the POA, and both large and small cells in the dorsomedial areas; POm and POp. The 
hypothalamic POA are known to have GnRH1 expressing neurons (Moriya et al., 2013), 
which is the form of GnRH found to be hypophysiotropic and thus control gonad 
development and maturation in most teleosts (Oka, 2009). Most vertebrate species 
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investigated, shows co-localization of kiss receptor genes and GnRH1 (Parhar et al., 2004), 
emphasizing the kiss system’s direct regulatory role during reproductive control. Some 
exceptions to this is found in certain teleost species, including the European sea bass (Escobar 
et al., 2013) and medaka (Kanda et al., 2013), where no co-localization could be observed. 
However, kiss receptor expression (including medaka gpr54-chr9) was found in close 
proximity to gnrh1 in both studies, leaving a possibility of indirect Kiss regulation of GnRH 
neuron activity through interneurons. It is found that Kiss1 neurons in the NVT area of 
medaka sends projections to the POA, (Hasebe et al., 2014), which further indicates that 
Kiss1 in the NVT can control the GnRH neurons in the POA. The cell clusters of relatively 
large, distinctive cells, found around the POA in my experiments are therefore possibly 
interneurons, linking the kiss system to GnRH1 neurons in the reproductive axis. The smaller, 
expressing cells that were found in my experiments, mainly in the ventral telencephalon areas, 
looked different from the cells described above. My suggestion is that these cells exert some 
other physiological function in the animal, either somehow linked to reproduction or 
reproductive behavior, or having some other role in the animal. It is well known that many of 
the areas of gpr54-chr9 expression, like the POA and the ventral telencephalon, are important 
in regulating several homeostatic events, like regulating reproduction and reproductive 
behaviors in teleost species (Satou et al., 1984). 
In the areas I found to express gpr54-chr9, there were a tendency of many cells showing 
expression, especially in the preoptic areas, but the expression level in each cell appeared to 
be low. Too low levels of expression could be an explanation for the lack of expression in 
habenula: since the expression level already was low in the other areas showing expression, 
reduced levels in this area could lead to the fluorescent emission falling below the detection 
limit. In fact, in my analyzes indicate some labelling in the habenula, but it was too weak and 
diffuse to make any firm conclusion. If low expression level is the problem, small adjustments 
to the method to increase the expression level and reduce the background could be a 
breakthrough in the detection of habenula gpr54-chr9 labelling. In the expression map 
published by Kanda et al. (2013), the habenula expression signal appears a bit weak compared 
to the other expressed areas. In this study the expression pattern is revealed by classical in situ 
hybridization, which proves to be a more sensitive method compared to FISH (see 
Introduction). Further, the lack of gpr54-chr9 expression in my experiments, compared to the 
findings of Kanda et al. (2013) might be a result of fish specific differences between the two 
aquarium facilities. Different handling of the fish could affect the kiss system expression 
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level, as Kiss1 localized in the habenula is found to be affected by fear in zebrafish (Ogawa et 
al., 2014). Habenula Gpr54 is not restricted to medaka, as expression is reported in several 
other vertebrate species, in both mammals (rodent species: mice and rats; Herbison et al., 
2010; Lee et al., 1999) and other teleosts (zebrafish and european sea bass respectively; 
Escobar et al., 2013; Ogawa et al., 2012). The habenula expression in these two teleost 
species has proven to be dense. As habenula Gpr54 expression appears to be a vertebrate wide 
phenomenon, the lack of detection during my study might be a cause of too low sensitivity of 
the method. To find out if expression was present in the habenula of our medaka, a qPCR 
could have been performed on dissected habenula tissue. This is a much more sensitive 
method, which probably could have detected any low-level gpr54-chr9 expression present, 
but I did not have the time to do so. 
The expression pattern found in medaka in my experiments, and by Kanda et al. (2013) shows 
a different spatial expression pattern in the brain compared to what is found for the receptor 
ortholog in zebrafish (Ogawa et al., 2012) and in the European sea bass (Escobar et al., 2013). 
Zebrafish expression of this gene is found mainly in the habenula, where the expression is 
most abundant, and in the POp in the ventral hypothalamus. However, expression is also 
found in far more posterior areas, like nucleus fasciculus longitudinalis medialis (NFLM) and 
nucleus posterioris periventricularis (NPPv) of the mesencephalon, and additional low 
expression in the cerebellum of rhombencephalon. The European sea bass has an expression 
pattern more similar to medaka, but still showing some differences. Here, expression is found 
restricted to the areas of the ventral telencephalon, the preoptic areas and habenula, like in 
medaka, and additional expression found in a few cells in the mediobasal hypothalamus of the 
mesencephalon and dense expression showing in the pituitary. All the three teleost species 
have some expression in the preoptic areas common, in addition to the habenula expression. 
The many differences in the expression patterns between medaka and zebrafish is not 
surprising, as the kiss1 and kiss2 expression patterns between the two species is shown to 
differ notably, and also showing physiological differences in regulating the reproductive axis 
(see Introduction). Mammals lack this current receptor ortholog (see Introduction), but have 
another homolog in a different receptor clade, GPR54-1, showing wide distribution of 
expression in many areas throughout the brain, differing from both the teleosts’ expression 
patterns (Herbison et al., 2010). But what is similar for all vertebrate species investigated is 
that the kiss receptor gene is expressed in, or proximate to, the GnRH neurons that control the 
reproductive axis.  
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From the findings discussed in the above paragraphs, it is clear that the expression pattern of 
gpr54-chr9 found in my experiments correlates well with the available expression map in 
medaka. The expression pattern differs somewhat from what is found in other vertebrates, 
also in other teleosts, which might indicate that the receptor has intraspecies functional 
differences.  
4.2 In situ hybridization in embryonic medaka 
Seen from the expression of cxcr4a, which I used as positive control, the in situ hybridization 
method worked in embryos as well. However, no labeling was found with the gpr54-chr9 
probe in embryos. It is known from the qPCR studies performed by Hodne et al. (2013) that 
gpr54-chr9 expression is present in all stages of embryonic medaka. Either the use of gpr54-
chr9 probe by FISH needs further modifications for the use on embryos, or the expression 
level is below the detection limit of this method.  
Because of Gpr54-chr9’s central role in the brain of adult medaka, and its predicted role in the 
developing brain seen from the knockdown studies performed by Hodne et al. (2013), a 
suggestion will be that expression is seen in the developing brain. The gene knockdown and 
partial knockdown (Hodne et al., 2013) resulted in developmental arrest, possibly as a result 
of affected neuron migration, and morphological defects of the developing brain and eyes 
region occurring, respectively (see Introduction). Therefore, during the search for embryonic 
expression of gpr54-chr9, my main area of focus was the developing brain, but the rest of the 
developing embryo was also carefully investigated. In addition, gpr54-chr9 might show 
expression in close proximity to GnRH1 neurons in embryos, similar to what is seen in the 
adult brain. The expression of gnrh1 has been mapped through embryonic development in 
medaka (Okubo et al., 2006; Parhar et al., 1998). Two gnrh1 expressing neuronal clusters 
develop. The first cluster emerges at 2 dpf bilaterally around the nasal area and the dorsal 
telencephalon. As the development reach 4 dpf, the neural population has migrated posterior 
into the forebrain through the ventral telencephalon to the POA, and when reaching 20 dpf the 
neurons have developed extended projections to the pituitary. The other cluster emerges first 
at 4 dpf bilaterally in the anterior telencephalon, developing through a more medial route, 
reaching the ventral telencephalon at 10 dpf. If the gpr54-chr9 probe starts working in 
embryo, then expression might be seen in proximity to these migratory routes. 
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Despite this lack of gpr54-chr9 labelling, the FISH method was successfully adapted to 
embryonic expression analyses with the cxcr4a probe. Both tyramide colorings, TAMRA and 
FITC were proven to work in embryos for this positive control. Expression was distinctive 
around 1.5 dpf embryos, giving a characteristic labelling pattern in the brain and eye region. 
Bright expressing cells of specific labeling were found along the outer edge of the developing 
retina, following the shape of the eye cavity from an anterior point and further posterior to 
each eye, in the outer area of the brain. Cxcr4 are receptors working as important components 
in cell migration, among others in development (Wu et al., 2010). Teleost species have two 
paralogous variants of the gene; cxcr4a and cxcr4b (Sasado et al., 2008). The receptor ligand 
is Sdf1, which is considered an attractant for the cells containing the Cxcr4 receptor, thereby 
promoting cell migration. Because of the expected role of Gpr54-chr9 in neural migration and 
brain- and eye development, it could be interesting to explore the expression pattern of the 
gpr54-chr9 and cxcr4a in combination in a double FISH assay, searching for any potential co-
expression of the two receptor genes. Especially since cxcr4a was shown to be expressed in 
both the area of the developing brain and eye in 1.5 dpf embryos during my experiments. The 
establishment of two working labelling approaches in this thesis enables double FISH, and 
could be used for investigating this relationship, once the gpr54-chr9 probe is working in 
embryo. 
4.3 Further improvement of the method 
Further improvement of the method is needed to set up a working protocol using the gpr54-
chr9 probe in medaka embryos. Improvements affecting the rate of sensitivity of the method 
to reach above the detection limit, in addition to reducing the background staining is essential. 
First, the optimal probe concentration has to be found, needing more probe concentrations to 
be tested in embryos, to reveal the optimal dilution. Further, different probe hybridization 
temperatures could also be tested to find the ideal binding temperature (Yilmaz and Noguera, 
2004). The receptor probe is quite long (1215 bp), making it harder to reach the target 
transcript within the sample tissue and thus complicating the hybridization reaction. By 
decreasing the hybridization temperature slightly (from 65°C) the rate of hybridization will 
increase because of less energetic reagents, but a decrease in specificity is expected to follow 
(Thisse and Thisse, 2008). Even so, this increased hybridization could prove sufficient to 
reach an expression above the limit of detection. Another improvement worth trying is to 
change the viscosity of the probe mixture to increase the rate of probe reaching the target 
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transcripts. This was achieved by Lauter et al. (2011) by adding an viscosity-increasing 
polymer (5% dextran sulfate was used in this study) to the reaction buffer upon hybridization. 
Increased viscosity will increase the ability for the probe to reach the target of hybridization, 
giving a higher local concentration of the probe, resulting in a higher level of hybridization by 
significantly enhancing the signal intensity. Further, the POD inactivation efficiency after 
tyramide binding could be increased further to improve the expression to background level. 
This could be achieved by increasing the time of hydrogen peroxide treatment further, or it 
could be achieved by inactivation by another reagent; glycine-HCl (100 mM, pH 2.0), which 
is proven by Lauter et al. (2011) to give a more effective inactivation. A couple of test-runs 
using this inactivation procedure were performed, but there was no time for systematic 
testing. In the few runs tested, no significant effect was observed. Proper POD-inactivation 
could be even more crucial when working with double FISH, where complete inactivation is 
critical for good results. Improper inactivation could lead to false positive co-expression of 
the two probes tested (Gasnier et al., 2013). In addition, it is possible to include an additional 
amplification step, like stated in the protocol by Gasnier et al. (2013), for detection of low 
level expression. In this double signal amplification step, biotinyl-tyramide complexes are 
added to precipitate at the area of antibody-POD. A new round of -POD is added that 
specifically binds this complex, before the second tyramide complex is added coupled to 
fluorophores. The added tyramide-fluorophore complex is activated by the second POD, and 
precipitates around the POD-bound biotinyl-tyramides. By including this step an 
intensification of the fluorescent signal compared to original TSA FISH might be achieved, 
which could lead to increased signal of gpr54-chr9 in brain samples, or detection in embryo. 
Further, a shortened version of the probe could be made. Making a new, shorter version of the 
probe could be a turning point toward detecting gpr54-chr9 expressing cells in embryo. A 
shorter probe will more easily reach the targeted cytosol of the expressing cells, and might 
make detection possible. A downside is that by shortening the length of the probe, its 
specificity decreases (Thisse and Thisse, 2008).  
At last, it could have been wise to start the expression analysis in medaka embryo with a 
classical ISH to get an indication of the area of expression, since no expression map is yet 
published. In this way an indication of the area of expression is given, and screening of the 
different embryonic stages could be simpler, which overall could make the probe detection 
during expression analyses by FISH easier (Gasnier et al., 2013).  
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Unfortunately, the time I had available for adaptive testing was limited, rendering an 
undetectable gpr54-chr9 probe expression in embryo samples. Further, it could be that the 
embryonic expression level of pgr54-chr9 is too sparse, making it hard to adapt the settings to 
increase the stained expression pattern above detection limit, and thereby making the overall 
mRNA detection in embryo difficult by the FISH method.  
4.4 Summary 
The object of this thesis was divided in three defined aims 
First, I adapted a fluorescent in situ hybridization assay, originally optimized for zebrafish, to 
work in a medaka model of adult brain samples. This was a time-consuming process, with a 
lot of trouble-shooting, but eventually the adaptions contributed to getting the expression level 
above detection limit. A functional antisense gpr54-chr9 probe was established, and the 
expression pattern in the brain verified previously published expression maps in the medaka 
brain, thereby rendering the probe valid. With this in mind, the first aim of my study has been 
fulfilled. 
Second, the fluorescent in situ method was adapted to work in an embryonic medaka model. 
This was not achieved for the validated gpr54-chr9 probe, but for the positive control probe 
of cxcr4a. Either the gpr54-chr9 expression is too sparse to be detected by FISH, or this probe 
needs further probe-specific adaptions to work in embryos. This entails that the spatial-
temporal expression pattern of the gpr54-chr9 gene remains unknown for the time being, 
leaving this second aim just partly fulfilled.  
Last, I have through these experiments established two separate labelling approaches, working 
in both brain and embryonic samples. In this way it is now possible to do double-FISH assays, 
exploring gene expression of two genes in parallel, if two working probes are available. 
Thereby, the third aim of the study is fulfilled.  
4.5 Future experiments 
With my experiments ended, several doors open for future experiments. For instance, the 
FISH method using the gpr54-chr9 probe could be used on adult medaka brain from the 
transgene line of gnrh1:Gfp, available at our aquarium facility at the University of Oslo. This 
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future experiment can possibly confirm indirect kiss system regulation of GnRH1 neurons 
through Gpr54-chr9 containing interneurons, like found by Kanda et al. (2013), or if any 
gpr54-chr9 is expressed directly on the GnRH1 neurons, like seen in most species throughout 
the vertebrate subphylum (see Introduction). Further, if gpr54-chr9 containing interneurons 
are present, then a characterization of these cells could be performed by combining FISH 
using the gpr54-chr9 probe with immunohistochemistry using antibodies for various neuron-
specific proteins looking for potential co-localization and thereby characterize the gpr54-chr9 
cells.  
In addition, if the gpr54-chr9 probe was set to work in embryos, several interesting 
experiments could be set up besides finding the spatial expression pattern throughout 
embryogenesis. Like described previously, a double FISH assay combining the gpr54-chr9 
probe with the cxcr4a probe could reveal a possible co-localization of the two receptor genes 
during neural migration in the developing brain. Further, FISH using the gpr54-chr9 probe 
could be ran on embryos of the gnrh1:Gfp transgenic line, investigating if expression is found 
in GnRH neurons in embryo, or if the expression is similar to the situation found in adults. 
This could in addition render information about the kiss system’s regulation of GnRH1 
neurons during development, and might reveal if it regulates the development or the migration 
of the current neurons.  
Another thing worth looking into is if any changes to the gpr54-chr9 expression occur in 
embryos when the level of Kiss is manipulated, ether by Kiss ligand stimulation or by 
knockdown experiments using morpholinos (splice site blocking of specific transcripts by 
antisense oligos, like performed by Hodne et al. (2013)).  
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Appendix I: Plasmid pUC57 insert sequence  
Kiss receptor gpr54-chr.9: 
SP6: Sequence (5’3’) 
CATGATTACGCCAAGCTATTTAGGTGACACTATAGAATACTCAAGCTATGC
ATCAAGCT 
CDS: Sequence (5’3’) 
ATGTCTGCAGAACCGGCGACCATTGGGAGTCCGAACTGTGGCTCTGCGTGC
AACCTTTCCCTGGAGATCCCAACGCCACCGCAGCTGGTCGACGCCTGGTTG
GTGCCCACTTTCTTCTGCCTCATCATGCTGGTCGGTCTGGTCGGGAACTCGC
TGGTCATACATGTGATCACGAAGCATCAGCAGATGAAGACTGTCACCAAT
TTCTACATAGTCAATCTGGCTACTACTGACATCTTGTTCCTGGTGTGCTGCG
TTCCCTTCACCGCCACTCTGTACCCTCTGCCCAGCTGGATCTTTGGGGAGTT
CATGTGCCGTCTGGTCAATTATCTACAACAGGTGACTGCGCAGGCGACTTG
CATCACCCTGTCTGCCATGAGCGTGGACCGCTGCTATGTGACGGTCTATCC
TCTGCAGTCGCTGCGACACCGCACCCCCTGCTTGGCTCTGGCCGTCTCTGT
GTCCATCTGGATAAGCTCCTTGCTTCTGTCCATCCCTGTGGTCGTGTACACC
CGTCTAGAGGAAGGATACTGGTTTGGCCCACAGATTTACTGCAGCGAGGT
CTTCCCCTCTGCTTTTGTCCAGAGAGCCTTCATCATTTACAACTTTTTGGCC
ATCTACCTCCTCCCCCTTCTGACCATCGTTGCCTGTTACACCTTCATGCTCA
AGCGCATTGGCCGACCCAGTGTGAATCCCATCGACGGCAGCTACCAACTC
CAGGCTCAGGCGGAGCGAGCAGCAGCCGTCCGAGCTCGAGTCTCCCACAT
GGTGAAGGTTATAGTGGTCCTCTTCCTCATCTGCTGGGGCCCCATCCAGTT
CTGTGGGCTGCTGCAAGCTTTTGGCCTCCACAGCTACTTTCTATACAAACT
AAAGATTTGGGGCCACTGCTTGTCCTACTGCAACTCCTCCATCAACCCACT
GGTTTATGCCTTCATGGGCAACAACTTCAAGAAGGCTTTCAAACATGCTTT
CCCAGCCTTTCTTCTGTGGCGCGCCAGGAGAAGAGTCCGGGTGGGACATTT
AGACACGGAGGACGGCAGAGATCAGCAACCACCCAAAGGAGAAGCTGAG
CTGCATTTCCTTTCATCTGAGTCCTAA 
T7: Sequence (5’3’) 
CATCTAGAGGGCCCAATTCGCCCTATAGTGAGTCGTATTACAATTCA 
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Appendix II: Sequencing results 
Sequencing was done by Eurofin Genomics. The sequencing results were plotted into the 
GeneDoc computer program. Alignment of the sequence from Ensemble (KissRb_Ens), the 
sequence from NCBI, genebank (XM_0040722), the plasmid sequenced by SP6 primer 
(6a_12_SP6) and the plasmid sequenced by T7 primer, complimented and reversed 
(6a_12_T7cr). The two lower sequences are the sequenced plasmid, showing that I have the 
correct sequence inserted in the plasmid, as the sequence is comparable to the NCBI gene 
bank sequence.  
                                                                                                                        
                      *        20         *        40         *        60         *        80         *       100       
KissRb_Ens : ------------------------GGGAGTCCGAACTGTGGCTCTGCGTGCAACCTTTCCCTGGAGATCCCAACGCCACCGCAGCTGGTCGACGCCTGGT :   76
XM_0040722 : ATGTCTGCAGAACCGGCGACCATTGGGAGTCCGAACTGTGGCTCTGCGTGCAACCTTTCCCTGGAGATCCCAACGCCACCGCAGCTGGTCGACGCCTGGT :  100
6a_12_SP6  : --------CAGACCGGCGACCATTGGGAGTCCGAACTGTGGCTCTGCGTGCAACCTTTCCCTGGAGATCCCAACGCCACCGCAGCTGGTCGACGCCTGGT :   92
6a_12_T7cr : ---------------------------------------------------------------------------------------------------- :    -
                                     gggagtccgaactgtggctctgcgtgcaacctttccctggagatcccaacgccaccgcagctggtcgacgcctggt       
                                                                                                                        
                      *       120         *       140         *       160         *       180         *       200       
KissRb_Ens : TGGTGCCCACTTTCTTCTGCCTCATCATGCTGGTCGGTCTGGTCGGGAACTCGCTGGTCATA-CATGTGAT-CACGAAGCAT-CAGCAG-ATGAA-GACT :  171
XM_0040722 : TGGTGCCCACTTTCTTCTGCCTCATCATGCTGGTCGGTCTGGTCGGGAACTCGCTGGTCATA-CATGTGAT-CACGAAGCAT-CAGCAG-ATGAA-GACT :  195
6a_12_SP6  : TGGTGCCCACTTTCTTCTGCCTCATCATGCTGGTCGGTCTGGTCGGGAACTCGCTGGTCATA-CATGTGAT-CACGAAGCAT-CAGCAG-ATGAA-GACT :  187
6a_12_T7cr : ----------TCACTAGGGTTCCGGTCTCTTGTTCCG--GGGAAAGCTACGC-CTGGTCATATCATGTGATTCACGAAGCATTCAGCAGGATGAAAGACT :   87
             tggtgcccacTttCTtctGcctCatcaTgcTGgTCgGtctGGtcgGgaACtCgCTGGTCATA CATGTGAT CACGAAGCAT CAGCAG ATGAA GACT       
                                                                                                                        
                      *       220         *       240         *       260         *       280         *       300       
KissRb_Ens : G-TCACCAA-TTTCT-ACA--TAGTCAA--TCTGGCT-ACTACTGACA--TCTTGTTCCT----GGTGTGCTGCGTT--CCCTT-CACCG-CCACTCTGT :  253
XM_0040722 : G-TCACCAA-TTTCT-ACA--TAGTCAA--TCTGGCT-ACTACTGACA--TCTTGTTCCT----GGTGTGCTGCGTT--CCCTT-CACCG-CCACTCTGT :  277
6a_12_SP6  : G-TCACCAA-TTTCT-ACA--TAGTCAA--TCTGGCT-ACTACTGACA--TCTTGTTCCT----GGTGTGCTGCGTT--CCCTT-CACCG-CCACTCTGT :  269
6a_12_T7cr : GGTCACCCACTTTCTTACCATTAGTCAAATCCTGGCTTACTACTGACCATTCTTGTTTCTTGGTGGTGGCTGGCGTTTGCCCTTCCACCGGCCACTCTGT :  187
             G TCACCaA TTTCT ACa  TAGTCAA  tCTGGCT ACTACTGACa  TCTTGTTcCT    GGTGtgctGCGTT  CCCTT CACCG CCACTCTGT       
                                                                                                                        
                      *       320         *       340         *       360         *       380         *       400       
KissRb_Ens : A-CCCTCTGCCC-AG-CTGGATCTTT--GGGGA-GTTCATGTGCCGTCTGGTCAATTATCTACAACAGGTGACTGCGCAGGCGACTTGCATCACCCTGTC :  347
XM_0040722 : A-CCCTCTGCCC-AG-CTGGATCTTT--GGGGA-GTTCATGTGCCGTCTGGTCAATTATCTACAACAGGTGACTGCGCAGGCGACTTGCATCACCCTGTC :  371
6a_12_SP6  : A-CCCTCTGCCC-AG-CTGGATCTTT--GGGGA-GTTCATGTGCCGTCTGGTCAATTATCTACAACAGGTGACTGCGCAGGCGACTTGCATCACCCTGTC :  363
6a_12_T7cr : AATCCTCTGCCCCAGCCTGGATCATTTGGGGGAGGTTCATGTGCCGTCTGGTCAATTATCTACAACAGGTGACTGCGCAGGCGACTTGCATCACCCTGTC :  287
             A cCCTCTGCCC AG CTGGATCtTT  GGGGA GTTCATGTGCCGTCTGGTCAATTATCTACAACAGGTGACTGCGCAGGCGACTTGCATCACCCTGTC       
                                                                                                                        
                      *       420         *       440         *       460         *       480         *       500       
KissRb_Ens : TGCCATGAGCGTGGACCGCTGCTATGTGACGGTCTATCCTCTGCAGTCGCTGCGACACCGCACCCCCTGCTTGGCTCTGGCCGTCTCTGTGTCCATCTGG :  447
XM_0040722 : TGCCATGAGCGTGGACCGCTGCTATGTGACGGTCTATCCTCTGCAGTCGCTGCGACACCGCACCCCCTGCTTGGCTCTGGCCGTCTCTGTGTCCATCTGG :  471
6a_12_SP6  : TGCCATGAGCGTGGACCGCTGCTATGTGACGGTCTATCCTCTGCAGTCGCTGCGACACCGCACCCCCTGCTTGGCTCTGGCCGTCTCTGTGTCCATCTGG :  463
6a_12_T7cr : TGCCATGAGCGTGGACCGCTGCTATGTGACGGTCTATCCTCTGCAGTCGCTGCGACACCGCACCCCCTGCTTGGCTCTGGCCGTCTCTGTGTCCATCTGG :  387
             TGCCATGAGCGTGGACCGCTGCTATGTGACGGTCTATCCTCTGCAGTCGCTGCGACACCGCACCCCCTGCTTGGCTCTGGCCGTCTCTGTGTCCATCTGG       
                                                                                                                        
                      *       520         *       540         *       560         *       580         *       600       
KissRb_Ens : ATAAGTAAAGCACA---AACAAGCCC------------CATCTTTTCTGACGAAGGATACTGGTTTGGCCCACAGATTTACTGCAGCGAGGTCTTCCCCT :  532
XM_0040722 : ATAAGCTCCTTGCTTCTGTCCATCCCTGTGGTCGTGTACACCCGTCTAGAGGAAGGATACTGGTTTGGCCCACAGATTTACTGCAGCGAGGTCTTCCCCT :  571
6a_12_SP6  : ATAAGCTCCTTGCTTCTGTCCATCCCTGTGGTCGTGTACACCCGTCTAGAGGAAGGATACTGGTTTGGCCCACAGATTTACTGCAGCGAGGTCTTCCCCT :  563
6a_12_T7cr : ATAAGCTCCTTGCTTCTGTCCATCCCTGTGGTCGTGTACACCCGTCTAGAGGAAGGATACTGGTTTGGCCCACAGATTTACTGCAGCGAGGTCTTCCCCT :  487
             ATAAGctccttgCttctgtCcAtCCCtgtggtcgtgtaCAcCcgTctaGAgGAAGGATACTGGTTTGGCCCACAGATTTACTGCAGCGAGGTCTTCCCCT       
                                                                                                                        
                      *       620         *       640         *       660         *       680         *       700       
KissRb_Ens : CTGCTTTTGTCCAGAGAGCCTTCATCATTTACAACTTTTTGGCCATCTACCTCCTCCCCCTTCTGACCATCGTTGCCTGTTACACCTTCATGCTCAAGCG :  632
XM_0040722 : CTGCTTTTGTCCAGAGAGCCTTCATCATTTACAACTTTTTGGCCATCTACCTCCTCCCCCTTCTGACCATCGTTGCCTGTTACACCTTCATGCTCAAGCG :  671
6a_12_SP6  : CTGCTTTTGTCCAGAGAGCCTTCATCATTTACAACTTTTTGGCCATCTACCTCCTCCCCCTTCTGACCATCGTTGCCTGTTACACCTTCATGCTCAAGCG :  663
6a_12_T7cr : CTGCTTTTGTCCAGAGAGCCTTCATCATTTACAACTTTTTGGCCATCTACCTCCTCCCCCTTCTGACCATCGTTGCCTGTTACACCTTCATGCTCAAGCG :  587
             CTGCTTTTGTCCAGAGAGCCTTCATCATTTACAACTTTTTGGCCATCTACCTCCTCCCCCTTCTGACCATCGTTGCCTGTTACACCTTCATGCTCAAGCG       
                                                                                                                        
                      *       720         *       740         *       760         *       780         *       800       
KissRb_Ens : CATTGGCCGACCCAGTGTGAATCCCATCGACGGCAGCTACCAACTCCAGGCTCAGGCGGAGCGAGCAGCAGCCGTCCGAGCTCGAGTCTCCCACATGGTG :  732
XM_0040722 : CATTGGCCGACCCAGTGTGAATCCCATCGACGGCAGCTACCAACTCCAGGCTCAGGCGGAGCGAGCAGCAGCCGTCCGAGCTCGAGTCTCCCACATGGTG :  771
6a_12_SP6  : CATTGGCCGACCCAGTGTGAATCCCATCGACGGCAGCTACCAACTCCAGGCTCAGGCGGAGCGAGCAGCAGCCGTCCGAGCTCGAGTCTCCCACATGGTG :  763
6a_12_T7cr : CATTGGCCGACCCAGTGTGAATCCCATCGACGGCAGCTACCAACTCCAGGCTCAGGCGGAGCGAGCAGCAGCCGTCCGAGCTCGAGTCTCCCACATGGTG :  687
             CATTGGCCGACCCAGTGTGAATCCCATCGACGGCAGCTACCAACTCCAGGCTCAGGCGGAGCGAGCAGCAGCCGTCCGAGCTCGAGTCTCCCACATGGTG       
                                                                                                                        
                      *       820         *       840         *       860         *       880         *       900       
KissRb_Ens : AAGGTTATAGTGGTCCTCTTCCTCATCTGCTGGGGCCCCATCCAGTTCTGTGGGCTGCTGCAAGCTTTTGGCCTCCACAGATGCATGCAAAAATCTCTTT :  832
XM_0040722 : AAGGTTATAGTGGTCCTCTTCCTCATCTGCTGGGGCCCCATCCAGTTCTGTGGGCTGCTGCAAGCTTTTGGCCTCCACAGCTAC---------------- :  855
6a_12_SP6  : AAGGTTATAGTGGTCCTCTTCCTCATCTGCTGGGGCCCCATCCAGTTCTGTGGGCTGCTGCAAGCTTTTGGCCTCCACAGCTAC---------------- :  847
6a_12_T7cr : AAGGTTATAGTGGTCCTCTTCCTCATCTGCTGGGGCCCCATCCAGTTCTGTGGGCTGCTGCAAGCTTTTGGCCTCCACAGCTAC---------------- :  771
             AAGGTTATAGTGGTCCTCTTCCTCATCTGCTGGGGCCCCATCCAGTTCTGTGGGCTGCTGCAAGCTTTTGGCCTCCACAGcTaC                       
                                                                                                                        
                      *       920         *       940         *       960         *       980         *      1000       
KissRb_Ens : TCTTTTACTTCCAGCTAAAGATTTGGGGCCACTGCTTGTCCTACTGCAACTCCTCCATCAACCCACTGGTTTATGCCTTCATGGGCAACAACTTCAAGAA :  932
XM_0040722 : -TTTCTATACAAA-CTAAAGATTTGGGGCCACTGCTTGTCCTACTGCAACTCCTCCATCAACCCACTGGTTTATGCCTTCATGGGCAACAACTTCAAGAA :  953
6a_12_SP6  : -TTTCTATACAAACTAAAAGATTTGGGGCCACTGCTTGTCCTACTGCAACTCCTCCATCAACCCACTGG------------------------------- :  915
6a_12_T7cr : -TTTCTATACAAA-CTAAAGATTTGGGGCCACTGCTTGTCCTACTGCAACTCCTCCATCAACCCACTGGTTTATGCCTTCATGGGCAACAACTTCAAGAA :  869
              tTTcTAtacaaA ctAAAGATTTGGGGCCACTGCTTGTCCTACTGCAACTCCTCCATCAACCCACTGGtttatgccttcatgggcaacaacttcaagaa       
                                                                                                                        
                      *      1020         *      1040         *      1060         *      1080         *      1100       
KissRb_Ens : GGCTTTCAAACATGCTTTCCCA------------------------------------------------------------------------------ :  954
XM_0040722 : GGCTTTCAAACATGCTTTCCCAGCCTTTCTTCTGTGGCGCGCCAGGAGAAGAGTCCGGGTGGGACATTTAGACACGGAGGACGGCAGAGATCAGCAACCA : 1053
6a_12_SP6  : ---------------------------------------------------------------------------------------------------- :    -
6a_12_T7cr : GGCTTTCAAACATGCTTTCCCAGCCTTTCTTCTGTGGCGCGCCAGGAGAAGAGTCCGGGTGGGACATTTAGACACGGAGGACGGCAGAGATCAGCAACCA :  969
             ggctttcaaacatgctttccca                                                                                     
                                                                                
                      *      1120         *      1140         *      1160       
KissRb_Ens : ------------------------------------------------------------ :    -
XM_0040722 : CCCAAAGGAGAAGCTGAGCTGCATTTCCTTTCATCTGAGTCCTAA--------------- : 1098
6a_12_SP6  : ------------------------------------------------------------ :    -
6a_12_T7cr : CCCAAAGGAGAAGCTGAGCTGCATTCCCTTCATTGCGTAAAAACGACGACACAGAAACGA : 1029
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Appendix III: Buffer recipes 
Hybridization mix: 
Deionized formamide  
SSC 20× 
Tween 10% 
Citric acid 1M 
Heparin (50 mg/mL stock) 
Torula/yeast RNAt (10 mg/mL stock) 
Nuclease free water 
25 mL 
12.5 mL 
500 µL 
770 µL 
15 µL 
400 µL 
Complete total volume to 50 mL 
- Store in the freezer at - 20°C 
Hybridization wash: 
Formamide  
SSC 20× 
Tween 10% 
Citric acid 1M 
Nuclease free water 
25 mL 
12.5 mL 
500 µL 
770 µL 
Complete total volume to 50 mL 
- Store in the freezer at - 20°C, or at RT overnight 
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MAB 
Maleic acid 250 mM 
NaCl 5M 
Tween 10% 
Nuclease free water  
200 mL 
15 mL 
5 mL 
Complete total volume to 500 mL 
- Adjust pH with NaOH pellets until pH=7.5. Store at RT.  
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Appendix IV: Medium recipes 
 
E3-medium 
 
NaCl 
KCl 
CaCl2 
MgSO4 
RO water 
Methylene Blue 
5.0 mM 
0.17 mM 
0.33 mM 
0.33 mM 
 
- Store in the fridge, or for shorter periods at incubating temperature 
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Appendix V: Tyramide-component synthesis  
TAMRA and FITC tyramide synthesis was prepared in the lab, by the protocol 
Fluorescein-tyramide synthesis (provided by L. Davidson): 
http://www.xenbase.org/other/static/methods/FISH.jsp 
TAMRA or FITC tyramide synthesis 
1. Make a 10 mg/ml stock of the NHS ester (NHS-Rhodamine or NHS-fluorescein ester; 
Pierce) in dimethyl formamide (DMF). 
2. Make DMF-TEA solution: 1 ml DMF added 10 ul TEA (triethylamine). 
3. Make tyramide solution: 10 mg tyramide in 1 ml DMF-TEA. 
Mix 2.5 ml NHS ester stock in DMF with 822 l tyramide solution and incubate in dark at 
room temp for 2 hours. Add 21 ml 100 % ethanol, store in dark at -20°C. 
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Appendix VI: Fluorescent in situ hybridization protocol 
Embryos / Conditions: Starting point = dehydrated embryos stored in methanol. 
Preparations: Prepare in situ program. Make necessary calibrations of the machine. Check 
available probes, synthesize new probes if empty.  
Day 1 
Single – and double FISH 
Rehydratation 
Rehydrate the embryos through an ethanol/PBST series (100%, 75%, 50%, 25% ethanol 
mixed with PBST) 5 minutes per wash 
 Put embryos or brains in appropriate well (with grid underneath) and set well in 
appropriate basket in 100 % ethanol. Use appropriate amount of liquid (so that all samples are 
covered with liquid). Start probrame: 
  SetTemp RT     
  Incubate 00:10 h:m,  ETOH   75 %                x 2 
  Incubate 00:10 h:m,  ETOH    50%  x 2 
  Incubate 00:10 h:m,  ETOH   25 %               x 2 
  Incubate 00:05 h:m,  PBST WASH               x 2 
  Incubate 00:15 h:m,  PBST WASH               x 2 
  Pause…….. 
 
Proteinase K treatment 
Digest with Proteinase K manually according to the sample type; embryo stage/brain. 
 At ended enzyme incubation, start the programe at the glycine step. 
 SetTemp RT   
 Incubate 00:30 h:m,  Glycine 1X     
 Incubate 00:05 h:m,  PBSt   x 5 
 Incubate 00:20 h:m,  PBSt   x 2 
Hybridation: 
 Prepare Hybridization mix (HybMix) and Hybridization wash (HybWash, needed the next 
day).  
 Prehybridize embryos in HybMix, 4 hrs at 65°C.  
 Prepare HybMix+probe solutions (concentration is probe specific) 
 Heat probes 10 min 90°C (denaturation; heating block). Put directly on ice afterwards.  
   SetTemp ON  65°C 
   Incubate 04:00 h:m,  HybMix 
   Incubate 15:00 h:m,  Probe solution; step overnight 
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Day 2 
 
Wash 
 Prepare buffers and heat the buffers to 65 °C for 1 hour.  
  SetTemp ON  65°C  
  Incubate 00:15 h:m,  100%Hyb  2x   
  Incubate 00:20 h:m,  75%Hyb/25% SSC 2X     
  Incubate 00:20 h:m,  50%Hyb/50%SSC 2X     
  Incubate 00:20 h:m,  25%Hyb/75%SSC 2X 
  Incubate 00:20 h:m,  SSC 2X     
  Incubate 00:20 h:m,  SSC 0.2X  x 2 
 
  SetTemp RT     
  Wait               00:30 h:m - to cool down    
  Incubate 00:05 h:m,  PBSt   x 5 
 Incubate 00:20 h:m,  PBSt   x 2 
 
Endogenous peroxidase inactivation 
 Prepare H2O2 2%  (diluted in PBST)  
 SetTemp RT  
 Incubate 00:30 h:m,  H2O2 2%   
 Incubate 00:06 h:m,  PBSt   x 5 
 Incubate 00:20 h:m,  PBSt   x 2 
 
Blocking 
 Prepare blocking Buffer: 1/10 Blocking in MAB  
SetTemp RT   
Incubate 02:00 h:m,  blocking 
Pause…….. 
 
Antibody incubation 
Add Antibody manually: 1/150 Anti-DIG POD or anti-FITC 1/200 in blocking buffer + 
MAB; 200 µL per well. Incubation at 4 °C overnight.  
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Day 3 
 
Wash  
 Wash samples: 
  SetTemp RT 
  Incubate 00:06 h:m,  PBST   x 5 
  Incubate 00:20 h:m,  PBST   x 2 
 
Tyramide 
 Prepare 0,003% H2O2 (in PBST) 
 Prepare Tyramide-TAMRA (1/100 in PBST) +0,003% H2O2 (1/10), 45 min incubation at 
RT or Tyramide-FITC (1/200 in PBST) +0,003% H2O2 (1/10), 30 min incubation at RT  
 
SetTemp RT 
Incubate  00:45 h:m,  tyr-TAMTA   
…or 
Incubate  00:30 h:m,  tyr-FITC    
  
 Wash in PBSt 
SetTemp RT  
 Incubate 00:06 h:m,  PBSt   x 5 
 
Ab peroxidase inactivation 
 Prepare H2O2 2% (diluted in PBST) 
 SetTemp RT  
 Incubate 01:00 h:m,  H2O2 2% 
 Incubate 00:06 h:m,  PBSt   x 5  
 Incubate 00:20 h:m,  PBSt   x 2 
 
- Single FISH, method ended! 
Double FISH: 
Blocking 
 Prepare blocking Buffer: 1/10 Blocking in MAB    
SetTemp RT 
Incubate 01:00 h:m,  blocking 
Pause…….. 
 
Antibody incubation 
Add second antibody manually: 1/150 Anti-DIG POD or anti-FITC 1/200 in blocking 
buffer + MAB; 200 µL per well. Incubation at 4 °C overnight.  
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Day 4 
 
Wash  
 Wash samples: 
SetTemp RT   
Incubate  00:05 h:m,  PBST   x 5 
 Incubate 00:20 h:m,  PBST   x 2 
 
Tyramide 
 Prepare 0,003% H2O2 (in PBST) 
 Prepare second tyramide,  Tyramide-TAMRA (1/100 in PBST) +0,003% H2O2 (1/10), 45 
min incubation at RT or Tyramide-FITC (1/200 in PBST) +0,003% H2O2 (1/10), 30 min 
incubation at RT  
 
SetTemp RT 
Incubate  00:45 h:m,  tyr-TAMTA   
…or 
Incubate  00:30 h:m,  tyr-FITC    
  
 Wash in PBSt 
SetTemp RT  
Incubate  00:06 h:m,  PBSt   x 5 
 
Ab peroxidase inactivation 
 Prepare H2O2 2% (diluted in PBST) 
SetTemp RT   
Incubate  00:30 h:m,  H2O2 2% 
Incubate 00:05 h:m,  PBSt   x 5  
Incubate 00:20 h:m,  PBSt   x 2 
 
- double FISH, method ended! 
 
 
 
 
